USPatent applicationPatented

Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV

Granted 15 Jan 2013 · no office action yet

Life of the application

8 dated events
⤢ drag to zoom200520102015202020252030ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

This application concerns certain 2-phenylamino-6-aryl amino-, 6-aryloxy-, and 6-arylthio-purines, -azapurines and -deazapurines. These compounds are non-nucleoside reverse transcriptase inhibitors and have potential as anti-HIV treatment.

Description

52 parts
›CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional patent application of U.S. application Ser. No. 11/919,786, filed Jan. 14, 2009, now U.S. Pat. No. 8,227,601 entitled “DIARYL-PURINES, -AZAPURINES AND -DEAZAPURINES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF HIV”, which is the national stage entry of PCT/US06/17677, filed May, 5, 2006, which claims priority to U.S. Provisional Application Ser. No. 60/678,667, filed May 5, 2005, all of which applications are incorporated herein by reference in their entirety.

›FIELD OF THE INVENTION

This application concerns certain 2-phenylamino-6-aryl amino-, 6-aryloxy-, and 6-arylthio-purines, -azapurines and -deazapurines. These compounds are non-nucleoside reverse transcriptase inhibitors and have potential as anti-HIV treatment.

›BACKGROUND OF THE INVENTION

Human Immunodeficiency Virus (HIV) presents a public-health and social catastrophe too well known to require documentation. One therapeutic approach to HIV has been inhibition of the viral RNA-dependent RNA polymerase; this enzyme is frequently referred to as “reverse transcriptase,” abbreviated “RT.” The first RT inhibitors were nucleoside analogs such as AZT and dd. Although such nucleoside RT inhibitors were frequently effective against the wild-type virus, any single-drug treatment has been hobbled by the virus's ability to readily produce drug-resistant mutants. This has led to an intense search for non-nucleoside RT inhibitors (“NNRTIs”) which are both effective and capable of retaining their effectiveness despite drug-resistance mutations. A recent review of NNRTIs can be found Balzarni, J., 2004, Cur. Top. Med. Chem. 4, 921-44 (Erratum ibid. 4, 1825).

Four leading NNRTI are: 1) Efavirenz (4S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; 2) Capravirine: 1H-Imidazole-2-methanol, 5-((3,5-dichlorophenyl)thio)-4-(1-methylethyl)-1-(4-pyridinylmethyl)-carbamate (ester); 3) Etravirine (TMC 125): 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile; and 4) Rilpivirine (TMC-278): 4-([4-[(4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl)amino]-2-pyrimidinyl)amino]benzonitrile. Rilpivirine and Etravirine belong to a subclass of NNRTIs called diarylpyrmidines (“DAPY”). For a review of these DAPY NNRTIs see Ludovici, D. W., et al., 2002, Bioorg. Med. Chem. Lett. 11, 2235-9. An extensive patent literature also exists for DAPY. U.S. Pat. No. 6,197,779; WO 00/27850; WO 2003/016306; and WO 2004/069812, all assigned to Janssen Pharmaceuticals.

Diaryl compounds similar to Etravirine and Rilpivirine where the pyrimidine moiety is replaced by a purine are described in WO 2005/028479, which also is assigned to Janssen.

›BRIEF DESCRIPTION OF THE INVENTION

The invention provides a compound of formula I

where the dashed line represents a double bond that may be located either between A and B or between B and D,

where A is —N═, N(Z) or C(Z);

B is CH or ═N—;

D is CW or ═N—, or N(W);

T is NH, O or S;

Z is H, F, Cl, Br, CH 3 , CH 2 CH 3 , cyclopropyl, or benzyl, in which the phenyl moiety of the benzyl group is optionally substituted with methyl or methoxy, provided that Z is not F or Cl when A is NZ;

W is H, F, Cl, Br, methyl, ethyl, cyclopropyl, allyl, CH 2 CF 3 , cyanomethyl, cyanoethyl, CH═CHCN, or benzyl, in which the phenyl moiety of the benzyl group is optionally substituted with one or two groups selected independently from methoxy and methyl, provided that W is not F or Cl when D is NW;

V is F, Cl, CN, SO 2 CH 3 , SO 2 NH 2 , SO 2 NHCH 3 , C≡CCH 3 , or CH═CHCN;

provided that when D is CW, A is not CZ and further provided that when neither A nor D is CZ or CW, then B is CH; and

Ar is selected from (a), (b), (c), and (d) below:

wherein each R P is selected from among methyl, ethyl, propyl, isopropyl, cyclopropylmethyl, or C 3 -C 6 cycloalkyl, cyano, CH═CHCN, Cl, Br, I, acetyl and alkylamino; R 4 , R 5 , and each R 6 are independently selected from among H, F, Cl, Br, CH 3 , CF 3 , CH 2 F, CHF 2 , isopropyl, cyclopropyl, OCH 3 , OH, OCF 3 , NH 2 and NHCH 3 , or R 6 and R p on adjacent ring atoms, together with the ring atoms to which they are attached, form an additional fused five-membered ring; Q and Q′ are independently selected from N and CH; R 7 is Cl, Br, I, CH 3 , CF 3 , OCH 3 , isopropyl, cyclopropyl, t-butyl, or cyclobutyl; and R 8 -R 11 are, independently, H or CH 3 .

Compounds of formula I have inhibitory activity against both wild-type and mutated forms of human immunodeficiency virus type 1 (HIV-1).

›DETAILED DESCRIPTION OF THE INVENTION · 1 of 2

In one embodiment this invention provides a compound of formula IA, in which the 6-linker T of formula I is T′, which may be O or S.

When T of formula I or T′ of formula IA is O, the invention excludes 1) compounds where both R p and V are CH═CHCN or cyano unless at least one of A or D is neither —N═ nor —NH— and 2) compounds where a) R is CH═CHCN, cyano, or methyl; b) V is cyano or CH═CHCN; and c) A and D are both one of —N═; N-benzyl or N-(substituted benzyl).

In one subgeneric embodiment, the invention provides a compound of formula IA where Ar is selected from 4-cyclopropyl phenyl; 4-cyclopropylmethyl phenyl; 4-bromophenyl; 4-cyclopropyl-naphth-1-yl; 2,6-dimethyl-4-cyanophenyl; 2,6-dimethoxy-4-cyanophenyl; 2,6-dimethyl-4-(2-cyanoethenyl)phenyl; 2,6-dimethoxy-4-(2-cyanoethenyl)phenyl; 2-methyl-4-cyclopropyl phenyl; 2,6-dimethyl-4-cyclopropyl phenyl; 2,6-di-trifluoromethyl-4-cyclopropyl phenyl; 2,4,6-trimethyl phenyl; and 2,6-dimethyl-4-acetyl phenyl.

In another subgeneric embodiment, the invention contemplates a compound of formula IA where Ar is selected from the following: 5-cyclopropyl-8-quinolyl; 5-isopropyl-8-quinolyl; 5-cyano-8-quinolyl; 5-cyclopropyl-7-trifluoromethyl-8-quinolyl; 5-acetyl-8-quinolyl; 5-cyano-7-methoxy-8-quinolyl; 5-cyano-7-methyl-8-quinolyl; 5-cyclopropyl-7-trifluoromethoxy-8-isoquinolyl; 5-cyano-8-isoquinolyl; 5-cyano-7-methoxy-8-isoquinolyl; 5-cyano-7-methyl-8-isoquinolyl; 5-cyclobutyl-7-difluoromethyl-8-isoquinolyl; 5,7-dimethyl-8-cinnolyl; 5-cyclopropyl-7-methyl-8-cinnolyl; and 5-(2-cyanoethenyl)-7-methyl-8-cinnolyl.

In another subgeneric embodiment, the invention provides a compound of formula IA-1

where Ar, V, W, and Z are defined as for formula I.

In another subgeneric embodiment, the invention provides a compound of formula IA-2

where Ar, V, W, and Z are defined as for formula I.

In another subgeneric embodiment, the invention provides a compound of formula IA-3

where Ar, V, W, and Z are defined as for formula I.

In another subgeneric embodiment, this invention provides a compound of formula IA-4

where Ar, V, W, and Z are defined as for formula I.

In another subgeneric embodiment, this invention provides a compound of formula IA-5

where Ar, V, W, and Z are defined as for formula I.

In another subgeneric embodiment, this invention provides a compound of formula IA-6

where Ar, V, W, and Z are defined as for formula I.

In another subgeneric embodiment, this invention provides a compound of formula IA-7

where Ar, V, W, and Z are defined as for formula I.

In another subgeneric embodiment, this invention provides a compound of formula IA-8

where Ar, V, W, and Z are defined as for formula I.

In another subgeneric embodiment, this invention provides a compound of formula IA-9

where Ar, V, W, and Z are defined as for formula I.

In another subgeneric embodiment, this invention provides a compound of formula IA-10

where Ar, V, W, and Z are defined as for formula I.

In another embodiment, this invention provides a compound of formula IB

where all substituents are as described above, except that when Ar is (c), this invention excludes compounds in which V is either cyano or CH═CHCN, unless A or D is CZ or CW.

In one subgeneric embodiment, the invention provides a compound of formula IB where Ar is (c), subject to the exclusion in the immediately preceding paragraph.

In a more specific subgeneric embodiment, the invention provides a compound of formula IB where Ar is

where R p is CN, CH═CHCN, or cyclopropyl; where R 6 and R 7 are either both methyl or both methoxy; and subject to the exclusion described above for formula IB.

In another subgeneric embodiment, this invention provides a compound of formula IB-1.

In another subgeneric embodiment, this invention provides a compound of formula IB-2.

where Ar, V, W, and Z are as described above for formula IB.

In another subgeneric embodiment, the invention provides a compound of formula IB-3.

where Ar, W, and Z are as described above for formula IB.

In another subgeneric embodiment, the invention provides a compound of formula IB-4.

where Ar, V, and Z are as described above for formula IB.

In more specific embodiments, the invention provides compounds of any of IA-1, IA-2, IA-3, IA-4, IA-5, IA-6, IA-7, IA-8, IA-9, IA-10, IB-1, IB-2, IB-3, and IB-4, where Ar is (a).

In additional more specific embodiments, the invention provides compounds of any of IA-1, IA-2, IA-3, IA-4, IA-5, IA-6, IA-7, IA-8, IA-9, IA-10, IB-1, IB-2, IB-3, and IB-4, where Ar is (b).

In additional more specific embodiments, the invention provides compounds of any of IA-1, IA-2, IA-3, IA-4, IA-5, IA-6, IA-7, IA-8, IA-9, IA-10, IB-1, IB-2, IB-3, and IB-4, where Ar is (c).

In additional more specific embodiments, the invention provides compounds of any of IA-1, IA-2, IA-3, IA-4, IA-5, IA-6, IA-7, IA-8, IA-9, IA-10, IB-1, IB-2, IB-3, and IB-4, where Ar is (d).

In a more specific subgeneric embodiment, this invention provides or contemplates a compound of formula IA-7, IA-8, IA-9, or IA-10, where Ar is 4-cyclopropyl-, 4-acetyl-, 4-methyl-, 4-bromo-, or 4-cyano-2,6-di-substituted phenyl.

In another more specific subgeneric embodiment, this invention provides or contemplates a compound of formula IA-1, IA-2, IA-3, or IA-4, where Ar is 4-cyclopropyl-, 4-acetyl-, 4-methyl-, 4-bromo-, or 4-cyano-2,6-di-substituted phenyl.

In another more specific subgeneric embodiment, this invention provides or contemplates a compound of formula IA-5 or IA-6, where Ar is 4-cyclopropyl-, 4-acetyl-, 4-methyl-, 4-bromo- or 4-cyano-2,6-di-substituted phenyl.

Synthetic Procedures

Compounds of this invention which are of the 7-deaza-8-azapurine type can be prepared according to Scheme 1.

Compound (1), 2-mercapto-6-hydroxy-7-deaza-8-aza-purine, can be synthesized by published procedures known to those skilled in the art. Youssif, S., et al., 2003, Bull. Kor. Chem. Soc., 24, 1429-32; Bontems, R. J., et al., 1990, J. Med. Chem. 33, 2174-8; Badger, G. M., & Rao, R. P., 1965, Aust. J. Chem. 18, 1267-71.

Alternatively, the 7-deaza-8-azapurines can be synthesized according to Scheme 2, where “PMBCl” is p-methoxy benzyl chloride. The starting material is prepared by published procedures known to those skilled in the art. Seela, F., 1999, Helv. Chim. Act. 82, 105-124; Taylor, E., 1992, Tetrahedron 48, 8089-100; Seela, F., 1986, Helv. Chim. Act. 69, 1602-1613.

›DETAILED DESCRIPTION OF THE INVENTION · 2 of 2

The 8-aza-9-deazapurines of this invention can be synthesized according to Scheme 3. The synthesis of the starting material was described by Lewis, A. F., & Townsend, L. B., 1982, J. Am. Chem. Soc. 104, 1073-78.

The 9-deazapurines of this invention can be synthesized by Scheme 4. The synthesis of the starting material is described by Kielich, Klaus, ed., “Synthetic Communications” 2002 vol. 32, pp-3797-3802.

The 7-deazapurines of this invention are prepared by the procedure of Scheme 5. The starting material can be synthesized by the condensation of 2,6-diamino-1,2-dihydro[3H]pyrimidin-4-one with chloroacetaldehyde followed by treatment with phosphorus oxychloride, as indicated in Examples 1 and 3.

The purine compounds of this invention can be synthesized by strategies similar to those provided above, using N 7 -benzyl-2,6-dichloropurine as the starting material. This procedure is illustrated in WO 2005/028479.

Example 1
›Step AI

2-Amino-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one

To a mixture of 2,4-diamino-6-hydroxypyrimidine (20.0 g, 159 mmol) and NaOAc (26.0 g, 317 mmol) in H 2 O (300 mL) at 65° C. was added a solution of chloroacetaldehyde (22.0 mL, 50% in H 2 O, 173 mmol) in H 2 O (22 mL) dropwise for 90 min. The mixture was stirred at 65° C. for an additional 2 h and cooled to room temperature. The reaction mixture was concentrated in vacuo to one third of its original volume and stored at 4° C. for 16 h. The light pink precipitates were filtered, washed with an ice cold H 2 O (5 mL), and dried under high vacuum for 16 h. The precipitates were placed in Soxhlet extractor and refluxed with methanol (200 mL) for 24 h. The methanol was concentrated to give 13.3 g (56%) of 2-amino-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one as a light pink solid.

›Step A2

4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine

To a solution of 2-amino-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one (5.00 g, 33.3 mmol), dimethylaniline (4.22 mL, 41.0 mmol) and benzyltriethylammonium chloride (15.2 g, 66.6 mmol) in acetonitrile (25 mL) at room temperature under argon was added POCl 3 (18.6 mL, 200 mmol) dropwise for 30 min. The mixture was refluxed at 85° C. for 3 h and cooled to room temperature. The reaction was concentrated in vacuo to brown oil and to the oil was added an ice cold H 2 O (10 mL). The pH of the solution was adjusted to 5 by the addition of an aqueous NH 4 OH solution. Silica gel chromatography (CH 2 Cl 2 :MeOH=95:5) yielded 2.53 g (45%) of 4-chloro-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine as a light yellow solid. The product was then benzylated at N 7 using standard techniques.

›Step C

7-benzyl-4-(2,4,6-trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine

To a solution of 2,4,6-trimethylphenol (161 mg, 1.16 mmol) in 1-methyl-2-pyrridone (2 mL) in a sealed tube was added NaH (46 mg, 1.16 mmol). The reaction mixture was stirred at room temperature for 15 min and a solution of 7-benzyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine (100 mg, 0.39 mmol) in 1-methyl-2-pyrridone (1 mL) was added to the mixture. The mixture was heated at 150° C. for 16 h and cooled to room temperature. The reaction mixture was poured into ice water and extracted with EtOAc (2×20 mL). The combined organic solution was washed with H 2 O (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 107 mg (77%) of 7-benzyl-4-(2,4,6-trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine.

›Step D

7-benzyl-2-fluoro-4-(2,4,6-trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidine

To 7-benzyl-4-(2,4,6-trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine (105 mg, 0.29 mmol) in a polyethylene flask at −50° C. under argon was added 60% HF in pyridine (12 mL). To the resulting solution tert-butylnitrite (0.052 mL, 0.44 mmol) was added dropwise for 5 min. The reaction was warmed to −40° C. and stirred for 30 min at the temperature. The reaction mixture was diluted with CHCl 3 (100 mL) and poured into K 2 CO 3 (3 g) in a beaker. Ice water (50 mL) was carefully added to the mixture. The CHCl 3 layer was separated, washed with aqueous NaHCO 3 solution (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 72 mg (68%) of 7-benzyl-2-fluoro-4-(2,4,6-trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidine as a light yellow solid.

›Step E

4-[7-benzyl-4-(2,4,6-trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile

To a solution of 4-aminobenzonitrile (101 mg, 0.86 mmol) in 1-methyl-2-pyrridone (1 mL) was added NaH (34 mg, 0.86 mmol). The reaction mixture was stirred at room temperature for 15 min and a solution of 7-benzyl-2-fluoro-4-(2,4,6-trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidine (62 mg, 0.17 mmol) in 1-methyl-2-pyrridone (1 mL) was added to the mixture. The mixture was stirred at room temperature for 1 h, poured into ice water, and extracted with EtOAc (2×20 mL). The combined organic solution was washed with H 2 O (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 64 mg (82%) of 4-[7-benzyl-4-(2,4,6-trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile.

›Step F

4-[4-(2,4,6-Trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile

To a solution of 4-[7-benzyl-4-(2,4,6-trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile (38 mg, 0.083 mmol) in 1,2-dichlorobenzene (1 mL) was added aluminum chloride (55 mg, 0.42 mmol). The reaction mixture was stirred at 160° C. for 4 h and cooled to room temperature. The mixture was poured into ice water and extracted with CH 2 Cl 2 (2×10 mL). The combined organic solution was washed with brine (10 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=50:50) yielded 15 mg (49%) of 4-[4-(2,4,6-trimethyl-phenoxy)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile as a tan solid.

Example 2
›Step A

7-benzyl-4-(2,4,6-trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine

To a solution of 2,4,6-trimethylbenzene-1-thiol (231 mg, 1.52 mmol) in 1-methyl-2-pyrridone (2 mL) was added NaH (58 mg, 1.52 mmol). The reaction mixture was stirred at room temperature for 15 min and a solution of 7-benzyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine (131 mg, 0.51 mmol) in 1-methyl-2-pyrridone (2 mL) was added to the mixture. The mixture was heated at 60° C. for 16 h and cooled to room temperature. The reaction was poured into ice water and extracted with EtOAc (2×20 mL). The combined organic solution was washed with H 2 O (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 180 mg (94%) of 7-benzyl-4-(2,4,6-trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine.

›Step B

7-benzyl-2-fluoro-4-(2,4,6-trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidine

To 7-benzyl-4-(2,4,6-trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine (155 mg, 0.41 mmol) in a polyethylene flask at −50° C. under argon was added 60% HF in pyridine (12 mL). To the solution was added tert-butylnitrite (0.074 mL, 0.62 mmol) dropwise for 5 min. The reaction was warmed to −40° C. and stirred for 30 min at the temperature. The reaction was diluted with CHCl 3 (100 mL) and poured into K 2 CO 3 (3 g) in a beaker. To the mixture was carefully added ice water (50 mL). The CHCl 3 layer was separated, washed with aqueous NaHCO 3 solution (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 118 mg (77%) of 7-benzyl-2-fluoro-4-(2,4,6-trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidine as a yellow solid.

›Step C

4-[7-benzyl-4-(2,4,6-trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile

To a solution of 4-aminobenzonitrile (184 mg, 1.56 mmol) in 1-methyl-2-pyrridone (2 mL) was added NaH (62 mg, 1.56 mmol). The reaction mixture was stirred at room temperature for 15 min and a solution of 7-benzyl-2-fluoro-4-(2,4,6-trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidine (118 mg, 0.31 mmol) in 1-methyl-2-pyrridone (2 mL) was added to the mixture. The mixture was stirred at room temperature for 4 h, then poured into ice water and extracted with EtOAc (2×20 mL). The combined organic solution was washed with H 2 O (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 123 mg (83%) of 4-[7-benzyl-4-(2,4,6-trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile.

›Step D

4-[4-(2,4,6-Trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile

To a solution of 4-[7-benzyl-4-(2,4,6-trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile (103 mg, 0.21 mmol) in 1,2-dichlorobenzene (2 mL) was added aluminum chloride (87 mg, 0.65 mmol). The reaction mixture was stirred at 160° C. for 1.5 h and cooled to room temperature. The mixture was poured into ice water and extracted with CH 2 Cl 2 (2×10 mL). The combined organic solution was washed with brine (10 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=50:50) yielded 28 mg (34%) of 4-[4-(2,4,6-trimethyl-phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile as a tan solid.

›Example 3

Steps A and B as in Example 1

›Step C

4-(2-Amino-7-benzyl-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile

To a solution of 4-hydroxy-3,5-dimethylbenzonitrile (1.62 mg, 11.0 mmol) in 1-methyl-2-pyrridone (5 mL) in a sealed tube was added NaH (441 mg, 11.0 mmol). The reaction mixture was stirred at room temperature for 15 min and a solution of 7-benzyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine (950 mg, 3.67 mmol) in 1-methyl-2-pyrridone (5 mL) was added to the mixture. The mixture was heated at 150° C. for 16 h and cooled to room temperature. The reaction was poured into ice water and extracted with EtOAc (2×50 mL). The combined organic solution was washed with H 2 O (50 mL) and brine (50 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 1.12 mg (83%) of 4-(2-amino-7-benzyl-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile.

›Step D

4-(7-benzyl-2-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile

To 4-(2-amino-7-benzyl-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile (70 mg, 0.19 mmol) in a polyethylene flask at −50° C. under argon was added 60% HF in pyridine (12 mL). To the solution was added tert-butylnitrite (0.068 mL, 0.57 mmol) dropwise for 5 min. The reaction was warmed to −40° C. and stirred for 30 min at the temperature. The reaction was diluted with CHCl 3 (100 mL) and poured into K 2 CO 3 (3 g) in a beaker. To the mixture was carefully added ice water (50 mL). The CHCl 3 layer was separated, washed with aqueous NaHCO 3 solution (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 36 mg (51%) of 4-(7-benzyl-2-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile.

›Step E

4-[7-benzyl-2-(4-cyano-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile

To a solution of 4-aminobenzonitrile (54 mg, 0.46 mmol) in 1-methyl-2-pyrridone (1 mL) was added NaH (18 mg, 0.46 mmol). The reaction mixture was stirred at room temperature for 15 min and a solution of 4-(7-benzyl-2-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile (34 mg, 0.091 mmol) in 1-methyl-2-pyrridone (1 mL) was added to the mixture. The mixture was stirred at room temperature for 1 h, poured into ice water, and extracted with EtOAc (2×20 mL). The combined organic solution was washed with H 2 O (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 28 mg (65%) of 4-[7-benzyl-2-(4-cyano-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile.

›Step F

4-[2-(4-Cyano-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile

To a solution of 4-[7-benzyl-2-(4-cyano-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile (28 mg, 0.060 mmol) in 1,2-dichlorobenzene (1 mL) was added aluminum chloride (40 mg, 0.30 mmol). The reaction mixture was stirred at 160° C. for 45 min and cooled to room temperature. The mixture was poured into ice water and extracted with CH 2 Cl 2 (2×10 mL). The combined organic solution was washed with brine (10 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=50:50) yielded 6 mg (27%) of 4-[2-(4-cyano-phenylamino)-71′-pyrrolo[2,3-d]pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile as a tan solid.

Example 4
›Step A

7-benzyl-N4-(2,4,6-trimethyl-phenyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine

To a suspension of 7-benzyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine (200 mg, 0.78 mmol) and 2,4,6-trimethylaniline (0.44 mL, 3.08 mmol) in 2,2,2-trifluoroethanol (4 mL) was added trifluoroacetic acid (0.48 mL, 6.24 mmol). The resulting solution was heated at 100° C. for 2 days and cooled to room temperature. The reaction was concentrated to brown oil and diluted with CH 2 Cl 2 (30 mL). The organic solution was washed with aqueous NaHCO 3 solution (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (CH 2 Cl 2 :MeOH=95:5) yielded 251 mg (90%) of 7-benzyl-N4-(2,4,6-trimethyl-phenyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine.

›Step B

(7-benzyl-2-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(2,4,6-trimethyl-phenyl)-amine

To 7-benzyl-N4-(2,4,6-trimethyl-phenyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine (251 mg, 0.70 mmol) in a polyethylene flask at −50° C. under argon was added 60% HF in pyridine (24 mL). To the solution was added tert-butylnitrite (0.42 mL, 3.5 mmol) dropwise for 10 min. The reaction was warmed to −40° C. and stirred for 30 min at the temperature. The reaction was diluted with CHCl 3 (200 mL) and poured into K 2 CO 3 (6 g) in a beaker. To the mixture was carefully added ice water (100 mL). The CHCl 3 layer was separated, washed with aqueous NaHCO 3 solution (40 mL) and brine (40 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 56 mg (22%) of (7-benzyl-2-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(2,4,6-trimethyl-phenyl)-amine.

›Step C

4-[7-benzyl-4-(2,4,6-trimethyl-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile

To a suspension of (7-benzyl-2-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(2,4,6-trimethyl-phenyl)-amine (42 mg, 0.12 mmol) and 4-aminobenzonitrile (55 mg, 0.47 mmol) in 2,2,2-trifluoroethanol (4 mL) was added trifluoroacetic acid (0.072 mL, 0.94 mmol). The resulting solution was heated at 90° C. for 16 h, then cooled to room temperature. The reaction was concentrated to produce a brown oil and diluted with CH 2 Cl 2 (30 mL). The organic solution was washed with H 2 O (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 34 mg (64%) of 4-[7-benzyl-4-(2,4,6-trimethyl-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile.

›Step D

4-[4-(2,4,6-Trimethyl-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile

To a solution of 4-[7-benzyl-4-(2,4,6-trimethyl-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile (34 mg, 0.074 mmol) in 1,2-dichlorobenzene (1 mL) was added aluminum chloride (50 mg, 0.37 mmol). The reaction mixture was stirred at 160° C. for 2 h and cooled to room temperature. The mixture was poured into ice water and extracted with CHCl 3 (2×10 mL). The combined organic solution was washed with brine (10 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (CH 2 Cl 2 :Acetone=90:10) yielded 5 mg (19%) of 4-[4-(2,4,6-trimethyl-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino]-benzonitrile as a tan solid.

Example 5
›Step A

4-(2-Amino-7-benzyl-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile

To a solution of 4-hydroxy-3,5-dimethylbenzonitrile (1.62 mg, 11.0 mmol) in 1-methyl-2-pyrridone (5 mL) in a sealed tube was added NaH (441 mg, 11.0 mmol). The reaction mixture was stirred at room temperature for 15 min and a solution of 7-benzyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine (950 mg, 3.67 mmol) in 1-methyl-2-pyrridone (5 mL) was added to the mixture. The mixture was heated at 150° C. for 16 h and cooled to room temperature. The reaction was poured into ice water and extracted with EtOAc (2×50 mL). The combined organic solution was washed with H 2 O (50 mL) and brine (50 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 1.12 mg (83%) of 4-(2-amino-7-benzyl-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile.

›Step B

4-(7-benzyl-2-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile

To 4-(2-amino-7-benzyl-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile (70 mg, 0.19 mmol) in a polyethylene flask at −50° C. under argon was added 60% HF in pyridine (12 mL). To the solution was added tert-butylnitrite (0.068 mL, 0.57 mmol) dropwise for 5 min. The reaction was warmed to −40° C. and stirred for 30 min at the temperature. The reaction was then diluted with CHCl 3 (100 mL) and poured into K 2 CO 3 (3 g) in a beaker. Ice water (50 mL) was carefully added. The CHCl 3 layer was separated, washed with aqueous NaHCO 3 solution (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 36 mg (51%) of 4-(7-benzyl-2-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile.

›Step C

4-[7-benzyl-2-(4-cyano-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile

To a solution of 4-aminobenzonitrile (54 mg, 0.46 mmol) in 1-methyl-2-pyrridone (1 mL) was added NaH (18 mg, 0.46 mmol). The reaction mixture was stirred at room temperature for 15 min and a solution of 4-(7-benzyl-2-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile (34 mg, 0.091 mmol) in 1-methyl-2-pyrridone (1 mL) was added to the mixture. The mixture was stirred at room temperature for 1 h, poured into ice water and extracted with EtOAc (2×20 mL). The combined organic solution was washed with H 2 O (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 28 mg (65%) of 4-[7-benzyl-2-(4-cyano-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile.

›Step D

4-[2-(4-Cyano-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile

To a solution of 4-[7-benzyl-2-(4-cyano-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile (28 mg, 0.060 mmol) in 1,2-dichlorobenzene (1 mL) was added aluminum chloride (40 mg, 0.30 mmol). The reaction mixture was stirred at 160° C. for 45 min and cooled to room temperature. The mixture was poured into ice water and extracted with CH 2 Cl 2 (2×10 mL). The combined organic solution was washed with brine (10 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=50:50) yielded 6 mg (27%) of 4-[2-(4-cyano-phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile as a tan solid.

›Examples19
›Example 6

4-Cyclopropyl-2,6-dimethylphenol

To a suspension of (4-bromo-2,6-dimethylphenoxy) tert-butyldimethylsilane (668 mg, 2.12 mmol) and tetrakis(triphenylphosphine)palladium (122 mg, 0.11 mmol) in THF (20 mL) was added cyclopropyl zinc chloride (28.0 mL, 11.2 mmol). The mixture was heated at 80° C. for 24 h and cooled to room temperature. The reaction was passed through a short pad of SiO 2 to remove the catalyst and the solution was concentrated to oil. The resulting oil was diluted in EtOAc (100 mL), washed with brine (100 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=90:10) yielded 370 mg (63%) of tert-butyl(4-cyclopropyl-2,6-dimethylphenoxy)dimethylsilane. To tert-butyl(4-cyclopropyl-2,6-dimethylphenoxy)dimethylsilane (320 mg, 1.16 mmol) in THF (10 mL) was added a solution of tetrabutylammonium fluoride (5.0 mL, 1 M in THF, 5.0 mmol) and acetic acid (0.40 mL). The reaction was stirred at room temperature for 3 h and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=85:15) yielded 175 mg (93%) of 4-cyclopropyl-2,6-dimethylphenol as a light yellow oil.

2-chloro-6-(4-cyclopropyl-2,6-dimethylphenoxy)-9H-purine

To a solution of 4-cyclopropyl-2,6-dimethylphenol (263 mg, 1.62 mmol) in 1-methyl-2-pyrridone (3 mL) at 0° C. was added NaH (65 mg, 1.62 mmol). The reaction mixture was stirred at room temperature for 30 min and a solution of 2,6-dichloropurine (102 mg, 0.54 mmol) in 1-methyl-2-pyrridone (2 mL) was added to the mixture. The mixture was heated at 100° C. for 16 h and then cooled to room temperature. The reaction was poured into ice water and extracted with CHCl 3 (3×20 mL). The combined organic solution was washed with H 2 O (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (MeOH:CHCl 3 =5:95) yielded 114 mg (67%) of 2-chloro-6-(4-cyclopropyl-2,6-dimethylphenoxy)-9H-purine.

4-(6-(4-cyclopropyl-2,6-dimethylphenoxy)-9H-purin-2-ylamino)benzonitrile

To a suspension of 2-chloro-6-(4-cyclopropyl-2,6-dimethylphenoxy)-91′-purine (28 mg, 0.088 mmol) and 4-aminobenzonitrile (42 mg, 0.35 mmol) in 2,2,2-trifluoroethanol (3 mL) in a sealed tube was added trifluoroacetic acid (0.056 mL, 0.70 mmol). The resulting solution was heated at 90° C. for 3 days. The reaction was cooled to room temperature and concentrated to dryness. Silica gel chromatography (CH 2 Cl 2 :Acetone=80:20) yielded 7 mg (20%) of 4-(6-(4-cyclopropyl-2,6-dimethylphenoxy)-9H-purin-2-ylamino)benzonitrile as a light yellow solid.

›Example 7

2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

To a suspension of 4-chloro-7H-pyrrolo[2,3-d]pyrimidin-2-ylamine (500 mg, 2.97 mmol) in 1,2-dichloroethane (40 mL) at −10° C. under argon was added antimony chloride (750 mg, 3.29 mmol). After stirring for 5 min, tert-butylnitrite (2.50 mL, 20.8 mmol) was added to the solution. The reaction was stirred at −10° C. for 3 h. The reaction was diluted with CHCl 3 (100 mL) and poured into ice water (50 mL). The CHCl 3 layer was separated, washed with brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=50:50) yielded 239 mg (43%) of 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine as a tan solid.

2-chloro-4-(4-cyclopropyl-2,6-dimethylphenoxy)-7H-pyrrolo[2,3-d]pyrimidine

To a solution of 4-cyclopropyl-2,6-dimethylphenol (259 mg, 1.60 mmol) in THF (3 mL) at 0° C. was added NaH (64 mg, 1.60 mmol). The reaction mixture was stirred at room temperature for 30 min and a solution of 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (100 mg, 0.53 mmol) in THF (2 mL) was added to the mixture. The mixture was heated at 80° C. for 16 h and cooled to room temperature. The reaction was poured into ice water and extracted with CHCl 3 (3×20 mL). The combined organic solution was washed with H 2 O (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (Hexanes:EtOAc=75:25) yielded 79 mg (48%) of 2-chloro-4-(4-cyclopropyl-2,6-dimethylphenoxy)-7H-pyrrolo[2,3-d]pyrimidine as a tan solid.

4-(4-(4-cyclopropyl-2,6-dimethylphenoxy)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)benzonitrile

To a suspension of 2-chloro-4-(4-cyclopropyl-2,6-dimethylphenoxy)-7H-pyrrolo[2,3-d]pyrimidine (75 mg, 0.24 mmol) and 4-aminobenzonitrile (113 mg, 0.96 mmol) in 2,2,2-trifluoroethanol (4 mL) in a sealed tube was added trifluoroacetic acid (0.15 mL, 1.92 mmol). The resulting solution was heated at 90° C. for 3 days. The reaction was diluted with EtOAc (50 mL), washed with NaHCO 3 (20 mL) and brine (20 mL), dried with Na 2 SO 4 , and concentrated to dryness. Silica gel chromatography (CH 2 Cl 2 :Acetone=90:10) yielded 15 mg (16%) of 4-(4-(4-cyclopropyl-2,6-dimethylphenoxy)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)benzonitrile as a tan solid.

›Example 8 · 1 of 2

Scheme 1 illustrate the synthesis of 9-deazaguanine by starting with commercially available 2-amino-6-methylpyrimidin-4(3H)-one and nitrated with nitric acid followed by treatment of the nitrated product with N,N-dimethylformamide dimethyl acetal (DMF-DMA) to afford the corresponding 2-(dimethylamino)methyleneimino derivative. It was then benzylated to produce 3-benzyl-2-[(dimethylamino)methyleneimino]-5-nitro-6-methylpyrimidin-4-one by treating with benzyl bromide and converted to benzylated-2,6-bis-dimethylaminomethylene derivative with DMF-DMA. Reductive cyclization with sodium hydrosulfite followed by de-protection with 3M NaOH and de-benzylation with Pd/C and NH 4 CO 2 H afforded 9-deazaguanine.

Scheme 2 illustrates the 3 different pathways which provide the various substituted 9-deazapurines. Other products are synthesized by analogous methods, which a person skilled in the art could formulate, based on the reaction sequences given above. In certain cases, the person skilled in the art would see that protecting groups might be necessary. The synthetic scheme can be summarized as follows.

Benzylation of 9-deazaguanine followed by chlorination with POCl 3 gives the chlorinated 9-deazapurine product. This chlorinated intermediate can either be coupled with R2 (pathway 1) followed by diazotization with t-butyl nitrite; displaced with F; coupled with R3 and de-benzylated to give the product; or it can undergo pathway 2, which is diazotization with t-butyl nitrite in the presence of antimony chloride followed by coupling with R2 and R3, followed by de-benzylation to afford the final product. Alternatively, pathway 3 provides for de-benzylation of the dichloro-9-deazapurine followed by the coupling with R2 and R3 respectively to provide the various substituted 9-deazapurine.

2-Amino-6-methyl-5-nitropyrimidin-4(3H)-one

To a mixture of 2-amino-6-methylpyrimidin-4(3H)-one (50 g, 0.4 mol) in 250 mL of H 2 SO 4 at 0° C. was added 40 mL of HNO 3 with an additional funnel. After being stirred at room temperature for 3 h, the reaction mixture was slowly poured into 3.6 L of diethyl ether and stirred for 15 min. Decant the ether solution and added 1.0 L of ethyl acetate to the solid and stirred for 10 h. The solid (54.8 g, 81% yield) was filtered and used for next step without any further purification.

(E)-N,N-Dimethyl-N′-(4-methyl-5-nitro-6-oxo-1,6-dihydropyrimidin-2-yl)formimidamide

To a suspension of 2-Amino-6-methyl-5-nitropyrimidin-4(3H)-one (54.8 g, 0.32 mol) in CH 2 Cl 2 (461 mL) was added DMF-dimethylacetal (103.1 mL, 0.77 mol) and stirred at room temperature for 1.5 h. The reaction mixture was filtered, washed with CH 2 Cl 2 , and used for the next step without further purification (31.9 g, 44% yield).

(E)-N′(1-benzyl-4-methyl-5-nitro-6-oxo-1,6-dihydropyrimidin-2-yl)-N,N-dimethylformimidamide

To a suspension of (E)-N,N-Dimethyl-N′-(4-methyl-5-nitro-6-oxo-1,6-dihydropyrimidin-2-yl)formimidamide (53.4 g, 0.24 mmol) in DMF (690 mL) was added DBU (44.6 mL, 0.30 mol) and benzyl bromide (44.4 mL, 0.29 mol) and stirred at room temperature for 1 h. The excess of DBU was neutralized with HCl, and the mixture was concentrated in vacuo. The residue was dissolved in methylene chloride and extracted twice with 2M HCl and water, then dried over Na 2 SO 4 and concentrated. Trituration with ethanol afforded the crystalline product which was washed with ethanol to give the product (64.7 g, 86% yield) and used in the next step without further purification.

(E)-N′-(1-benzyl-4-((E)-2-(dimethylamino)vinyl)-5-nitro-6-oxo-1,6-dihydropyrimidin-2-yl)-N,N-dimethylformimidamide

To a solution of (E)-N′(1-benzyl-4-methyl-5-nitro-6-oxo-1,6-dihydropyrimidin-2-yl)-N,N-dimethylformimidamide (64.7 g, 0.2 mol) in DMF (254 mL) was added DMF-dimethylacetal (54.5 mL, 0.41 mol). The reaction mixture was stirred for 3 h at 65° C., cooled, and the solvent was removed under reduced pressure. The residue was triturated with ethanol, and the solid was collected by vacuum filtration (69.2 g, 91%) and used in the next step without further purification.

(E)-N′-(3-benzyl-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-2-yl)-N,N-dimethylformimidamide

To a mixture of (E)-N′-(1-benzyl-4-((E)-2-(dimethylamino)vinyl)-5-nitro-6-oxo-1,6-dihydropyrimidin-2-yl)-N,N-dimethylformimidamide (43.0 g, 0.12 mol) in THF (151 mL) was added an aqueous saturated solution of Na 2 S 2 O 4 and stirred at room temperature overnight. Upon completion of the reaction, the solid was filtered and washed with THF to afford the product (21.2 g, 62% yield) which was used in the next step without further purification.

2-Amino-3-benzyl-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one

To a mixture of (E)-N′-(3-benzyl-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-2-yl)-N,N-dimethylformimidamide (21.2 g, 0.07 mol) in MeOH (382 mL) was added 3M NaOH (276 mL) and heated at 100° C. for 5 h. After completion of the reaction, the reaction mixture was cooled to 0° C. The solid was filtered (15.8 g, 91%) and used in the next step without further purification.

2-Amino-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one

To a mixture of 2-amino-3-benzyl-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one (10 g, 0.04 mol) in MeOH (334 mL) was added 10% Pd/C (2 g), ammonium formate (13.2 g, 0.21 mmol) and heated at 75° C. for 4 h. After completion of the reaction, the reaction mixture was cooled and filtered through a pad of Celite with hot 1:1 DMF/MeOH. The filtrate was concentrated in vacuo to provide the product as an off-white solid (6.2 g, 99%).

2-Amino-5-benzyl-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one

To a suspension of 2-amino-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one (336.7 mg, 2.0 mmol) in CH 2 Cl 2 (14.3 mL) was added benzyl bromide (0.26 mL, 2.2 mmol) and TBABr (644 mg, 2.0 mmol). The reaction mixture was cooled to 0° C., and to it was added 50% NaOH (1.7 mL). The resulting mixture was stirred for 2 h as it warmed from 0° C. to room temperature. Water was then added, and the solution was washed with CHCl 3 . The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. Purification by column chromatography, eluting with CH 2 Cl 2 /Acetone (5:1-1:1), afforded the product as a tan solid (423 mg, 82%)

›Example 8 · 2 of 2

5-benzyl-4-chloro-5H-pyrrolo[3,2-d]pyrimidin-2-amine

A mixture of 2-amino-5-benzyl-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one (1.1 g, 7.4 mmol) and POCl 3 (7 mL, 74 mmol) was heated at 116° C. for 3 h. Upon completion of the reaction, the reaction mixture was poured into ice and extracted three times with ethyl acetate. The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. Purification by column chromatography, eluting with CH 2 Cl 2 /Acetone (3:1), afforded the product as a white solid (490 mg, 40%).

5-benzyl-4-(mesityloxy)-5H-pyrrolo[3,2-d]pyrimidin-2-amine

To a stirred suspension of NaH (56 mg, 2.33 mmol) in dry NMP (2 mL) was added 2,4,6-trimethyl phenol (317 mg, 2.33 mmol). The mixture was stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 5-benzyl-4-chloro-5H-pyrrolo[3,2-d]pyrimidin-2-amine (200 mg, 0.78 mmol) in dry NMP (1.5 mL) and the resulting solution was heated at 90° C. for 16 h. After completion of the reaction, the reaction mixture was diluted with water and washed with EtOAc. The combined organic layers were washed with water, 2% NaOH, and brine and dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by column chromatography, eluting with hexanes/ethyl acetate (3:1) to give the product as a white solid (140 mg, 50%).

5-benzyl-2-fluoro-4-(mesityloxy)-5H-pyrrolo[3,2-d]pyrimidine

A solution of 5-benzyl-4-(mesityloxy)-5H-pyrrolo[3,2-d]pyrimidin-2-amine (139.9 mg, 0.39 mmol) in pyridine (1.6 mL) was cooled to −50° C. and HF-pyr (8 mL) and t-butyl nitrite (0.19 mL, 1.56 mmol) was added dropwise. The reaction mixture was stirred at 50° C. to −30° C. for 1.5 h. Upon completion of the reaction, the reaction mixture was poured into K 2 CO 3 (5 g), slowly added water and washed with CHCl 3 ×3. The combined organic layers were washed with brine, dried (Na 2 SO 4 ), filtered and concentrated in vacuo. The crude product was purified by silica gel column chromatography, eluting with hexanes/ethyl acetate (2:1) to give the product as a white solid (116 mg, 82%).

4-(5-benzyl-4-(mesityloxy)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

A stirred suspension of NaH (63.8 mg, 2.66 mmol) in dry NMP (1.5 mL) was added 4-aminobenzylnitrile (188 mg, 2.66 mmol) and stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 5-benzyl-2-fluoro-4-(mesityloxy)-5H-pyrrolo[3,2-d]pyrimidine (115 mg, 0.32 mmol) in dry NMP (1.7 mL) and stirred at room temperature for 2 h. After completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc 3 times. The combined organic layers were washed with water, NH 4 Cl, water×2, and brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by column chromatography, eluting with 1% MeOH:CH 2 Cl 2 , which afforded the product as a tan solid (120 mg, 80%).

4-(4-(Mesityloxy)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

To a suspension of 4-(5-benzyl-4-(mesityloxy)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile (150 mg, 0.33 mmol) in 1,2-dichlorobenzene (13 mL) was added AlCl 3 (436 mg, 3.27 mmol). The reaction mixture was heated at 160° C. for 1.5 h during which the reaction mixture became dark and homogeneous. Upon completion of the reaction, the reaction mixture was cooled and washed with NH 4 Cl. The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by column chromatography, eluting with Hexanes:Ethyl acetate (5:1-1:1) provided the product as a tan solid (27.8 mg, 23%).

›Example 9

4-(2-Amino-5-benzyl-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

To a stirred suspension of NaH (155 mg, 6.47 mmol) in dry NMP (4 mL) was added 4-hydroxy-3,5-dimethylbenzonitrile (570 mg, 3.88 mmol), and the mixture was stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 5-benzyl-4-chloro-5H-pyrrolo[3,2-d]pyrimidin-2-amine (400 mg, 1.55 mmol) in dry NMP (4 mL) and heated at 160° C. for 16 h. After completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc. The combined organic layers were washed with water, 2% NaOH, brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by column chromatography, eluting with hexanes/ethyl acetate (2:1-1:4) to give the product as a light yellow solid (342 mg, 60%).

4-(5-benzyl-2-fluoro-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

A solution of 4-(2-amino-5-benzyl-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile (319.4 mg, 0.87 mmol) in pyridine (3 mL) was cooled to −50° C. and HF-pyr (15 mL) and t-butyl nitrite (0.42 mL, 3.46 mmol) were added dropwise. The reaction mixture was stirred at −50° C. to −20° C. for 1.5 h. Upon completion of the reaction, the mixture was poured into K 2 CO 3 (8 g), diluted with water and washed with CHCl 3 ×3. The combined organic layers were washed with brine, dried (Na 2 SO 4 ), filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography, eluting with hexanes/ethyl acetate (2:1-1:1) which same the product as a light yellow solid (314 mg, 97%).

4-(5-benzyl-2-(4-cyanophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

To a stirred suspension of NaH (101 mg, 4.21 mmol) in dry NMP (4 mL) was added 4-aminobenzylnitrile (299 mg, 2.53 mmol) and stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 4-(5-benzyl-2-fluoro-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile (314 mg, 0.84 mmol) in dry NMP (4.4 mL) and stirred at room temperature for 2 h. After completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc×3. The combined organic layers were washed with water, NH 4 Cl, water×2, brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by column chromatography, eluting with 1% MeOH:CH 2 Cl 2 , producing the product as a tan solid (320 mg, 80%).

4-(2-(4-Cyanophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

To a suspension of 4-(5-benzyl-2-(4-cyanophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile (240 mg, 0.51 mmol) in 1,2-dichlorobenzene (20 mL) was added AlCl 3 (681 mg, 5.1 mmol). The reaction mixture was heated at 160° C. for 1.5 h, during which time the reaction mixture became dark and homogeneous. Upon completion of the reaction, the reaction mixture was cooled and washed with NH 4 Cl. The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered and concentrated in vacuo. The crude product was purified by preparative TLC TLC eluting with Hexanes:Ethyl acetate (2.5:1) and produced the product as a pink solid (51 mg, 26%).

›Example 10

5-benzyl-4-(mesitylthio)-5H-pyrrolo[3,2-d]pyrimidin-2-amine

To a stirred suspension of NaH (48 mg, 2 mmol) in dry NMP (2 mL) was added 2,4,6-trimethyl-benzene-1-thiol (191 mg, 1.2 mmol) The mixture was and stirred at room temperature for 30 min under argon. The reaction mixture was then added to a solution of 5-benzyl-4-chloro-5H-pyrrolo[3,2-d]pyrimidin-2-amine (103 mg, 0.4 mmol) in dry NMP (2.5 mL) and heated at 60° C. for 16 h. After completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc. The combined organic layers were washed with water, 2% NaOH, and brine; dried over Na 2 SO 4 ; filtered; and concentrated in vacuo. The crude product was purified by column chromatography, eluting with hexanes/ethyl acetate (2:1-1:3) to give the product as a light yellow solid (131 mg, 88%).

5-benzyl-2-fluoro-4-(mesitylthio)-5H-pyrrolo[3,2-d]pyrimidine

A solution of 5-benzyl-4-(mesitylthio)-5H-pyrrolo[3,2-d]pyrimidin-2-amine (131 mg, 0.35 mmol) in pyridine (1.6 mL) was cooled to −50° C. and added HF-pyr (8 mL) and t-butyl nitrite (0.17 mL, 1.4 mmol) dropwise. The reaction mixture was stirred at −50° C. to −40° C. for 1.5 h. Upon completion of the reaction, the reaction was poured into K 2 CO 3 (5 g), slowly added water and washed with CHCl 3 ×3. The combined organic layers were washed with brine, dried (Na 2 SO 4 ), filtered and concentrated in vacuo. The crude product was purified by silica gel column chromatography, eluting with hexanes/ethyl acetate (5:1-1:1) to give the product as an off-white solid (94 mg, 71%).

4-(5-benzyl-4-(mesitylthio)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

To a stirred suspension of NaH (30 mg, 1.25 mmol) in dry NMP (1.5 mL) was added 4-aminobenzylnitrile (87.4 mg, 0.74 mmol) and stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 5-benzyl-2-fluoro-4-(mesitylthio)-5H-pyrrolo[3,2-d]pyrimidine (93 mg, 0.25 mmol) in dry NMP (1 mL) and stirred at room temperature for 2 h. After completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc×3. The combined organic layers were washed with water, NH 4 Cl, water×2, brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by preparative TLC TLC, eluting with Hexanes:Ethyl acetate (1.5:1) afforded the product as a tan solid (12.6 mg, 11%).

4-(4-(mesitylthio)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

To a suspension of 4-(5-benzyl-4-(mesitylthio)-5H-pyrrolo[3,2-a]pyrimidin-2-ylamino)benzonitrile (9.2 mg, 0.03 mmol) in 1,2-dichlorobenzene (1 mL) was added AlCl 3 (26 mg, 0.3 mmol). The reaction mixture was heated at 160° C. for 1.5 h, which the reaction mixture became dark and homogeneous. Upon completion of the reaction, the reaction mixture was cooled and washed with NH 4 Cl. The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by preparative TLC TLC, eluting with Hexanes:Ethyl acetate (2.5:1) produced the product as a pink solid (7.7 mg, 20%).

›Example 11

5-benzyl-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine

To a suspension of 5-benzyl-4-chloro-5H-pyrrolo[3,2-d]pyrimidin-2-amine (641 mg, 2.5 mmol) in 1,2-dichloroethane (35 mL) was cooled to −10° C. SbCl 3 (850 mg, 3.7 mmol) was added. The reaction mixture was stirred for 5 min. t-butyl nitrite (2.1 mL, 17.4 mmol) was added dropwise and the stirred mixture was from −10° C. to room temperature for 5 h. Upon completion of the reaction, the reaction mixture was poured into ice water and washed with CH 2 Cl 2 . The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered and concentrated in vacuo. The crude product was purified by silica gel column chromatography eluting with Hexanes:Ethyl acetate (9:1-1:1), and gave the product as an off-white solid (528 mg, 77%).

2,4-Dichloro-5H-pyrrolo[3,2-d]pyrimidine

To a suspension of 5-benzyl-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine (177 mg, 0.64 mmol) in 1,2-dichlorobenzene (20 mL) was added AlCl 3 (852 mg, 6.4 mmol). The reaction mixture was heated at 160° C. for 1.5 h, during which the reaction mixture became dark and homogeneous. Upon completion of the reaction, the reaction mixture was cooled, added CHCl 3 and washed with NH 4 Cl. The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. Added Hexanes and filtered off the product as purple solids (100 mg, 80%) and used for the next step without further purification.

2-Chloro-4-(4-cyclopropyl-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidine

To a stirred suspension of NaH (25 mg, 0.64 mmol) in dry NMP (1.5 mL) was added 4-cyclopropyl-2,6-dimethylphenol (103 mg, 0.64 mmol) and the resolution mixture was stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine (120 mg, 0.64 mmol) in dry NMP (1.7 mL) and heated at 90° C. for 16 h. After completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc. The combined organic layers were washed with water, brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by column chromatography, eluting with hexanes/ethyl acetate (4:1-2:1), to give the product as a light yellow solid (20.2 mg, 8%).

4-(4-(4-Cyclopropyl-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

In a sealed tube was placed 2-chloro-4-(4-cyclopropyl-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidine (20 mg, 0.064 mmol), 4-aminobenzonitrile (31 mg, 0.26 mmol), TFE (0.21 mL) and TFA (0.04 mL, 0.51 mmol). The reaction mixture was stirred at 90° C. for 16 h. Upon completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc. The combined organic layers were washed with NaHCO 3 , brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by preparative TLC TLC, eluting with 5% Acetone/CH 2 Cl 2 to give the product as a light yellow solid (10.5 mg, 45%).

›Example 12

2-Chloro-4-(mesityloxy)-5-methyl-5H-pyrrolo[3,2-d]pyrimidine

To a stirred suspension of NaH (8.9 mg, 0.22 mmol) in dry NMP (1.0 mL) was added 2,4,6-trimethyl phenol (30.2 mg, 0.22 mmol) and stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 2,4-dichloro-5-methyl-5H-pyrrolo[3,2-d]pyrimidine (44.6 mg, 0.22 mmol) in dry NMP (1.0 mL) and heated at 90° C. for 16 h. After completion of the reaction, the resulting mixture was cooled, diluted with water and washed with EtOAc. The combined organic layers were washed with water, brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by column chromatography, eluting with hexanes/ethyl acetate (5:1-2:1), to give the product as a light yellow solid (52.7 mg, 80%).

4-(4-(Mesityloxy)-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

In a sealed tube was added 2-chloro-4-(mesityloxy)-5-methyl-5H-pyrrolo[3,2-d]pyrimidine (52.7 mg, 0.18 mmol), 4-aminobenzonitrile (83 mg, 0.70 mmol), TFE (1.0 mL) and TFA (0.11 mL, 1.44 mmol). The reaction mixture was stirred at 90° C. for 48 h. Upon completion of the reaction, the resulting mixture was cooled, diluted with water and washed with EtOAc. The combined organic layers were washed with NaHCO 3 , brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by preparative TLC, eluting with hexanes:ethyl acetate (5:1-2:1), to give the product as a light yellow solid

4-(2-Chloro-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

To a stirred solution of NaH (42.1 mg, 1.05 mmol) in dry NMP (2.5 mL) was added 4-hydroxy-3,5-dimethylbenzonitrile (154.7 mg, 1.05 mmol) and stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 2,4-dichloro-5-methyl-5H-pyrrolo[3,2-d]pyrimidine (211.3 mg, 1.05 mmol) in dry NMP (2.7 mL) and heated at 160° C. for 16 h. After completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc. The combined organic layers were washed with water, brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by column chromatography, eluting with hexanes/ethyl acetate (3:1-1:1), to give the product as a light yellow solid (294 mg, 85%).

4-(2-(4-Cyanophenylamino)-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

In a sealed tube was added 4-(2-chloro-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile (294 mg, 0.94 mmol), 4-aminobenzonitrile (455 mg, 3.77 mmol), TFE (3.1 mL) and TFA (0.58 mL, 7.52 mmol). The reaction mixture was stirred at 90° C. for 48 h. Upon completion of the reaction, the resulting mixture was cooled, diluted with water and washed with EtOAc. The combined organic layers were washed with NaHCO 3 , brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by preparative TLC, eluting with hexanes:ethyl acetate (4:1-1:2), to give the product as an off-white solid (133 mg, 40%).

›Example 13

1-(4-(5-benzyl-2-chloro-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylphenyl)ethanone

To a stirred solution of NaH (31 mg, 0.78 mmol) in dry NMP (2 mL) was added 1-(4-hydroxy-3,5-dimethylphenyl)ethanone (127 mg, 0.78 mmol) and stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 5-benzyl-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine (216 mg, 0.78 mmol) in dry NMP (2.4 mL) and heated at 160° C. for 16 h. After completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc. The combined organic layers were washed with water, 2% NaOH, brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by column chromatography, eluting with hexanes/ethyl acetate (4:1-2:1), to give the product as a light yellow solid (111 mg, 35%).

4-(4-(4-Acetyl-2,6-dimethylphenoxy)-5-benzyl-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

In a sealed tube was added 1-(4-(5-benzyl-2-chloro-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylphenyl)ethanone (111 mg, 0.27 mmol), 4-aminobenzonitrile (129 mg, 1.1 mmol), TFE (1.7 mL) and TFA (0.2 mL, 2.16 mmol). The reaction mixture was stirred at 90° C. for 16 h. Upon completion of the reaction, the resulting mixture was cooled, diluted with water, and washed with EtOAc. The combined organic layers were washed with NaHCO 3 and brine; dried over Na 2 SO 4 ; filtered; and concentrated in vacuo. The crude product was purified by silica gel column chromatography, eluting with hexanes:ethyl acetate (9:1-100% EtOAc), to give the product as an off-white solid (68 mg, 51%).

4-(4-(4-Acetyl-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

To a suspension of 4-(4-(4-acetyl-2,6-dimethylphenoxy)-5-benzyl-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile (65 mg, 0.13 mmol) in 1,2-dichlorobenzene (5.3 mL) was added AlCl 3 (178 mg, 1.3 mmol). The reaction mixture was heated at 160° C. for 1.5 h, after which time the reaction mixture became dark and homogeneous. Upon completion of the reaction, the reaction mixture was cooled, CHCl 3 was added, and the mixture was washed with NH 4 Cl. The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography, eluting with hexanes:ethyl acetate (3:1), to give the product as a brown solid (41 mg, 77%).

›Example 14

1-(4-(5-benzyl-2-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylphenyl)-N,N-dimethylmethanamine

To a stirred solution of NaH (80.4 mg, 1.0 mmol) in dry NMP (3 mL) was added 4-((dimethylamino)methyl)-2,6-dimethylphenol (216.4 mg, 1.0 mmol) and the mixture was stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 5-benzyl-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine (216 mg, 0.78 mmol) in dry NMP (2.6 mL) and heated at 120° C. for 16 h. After completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc. The combined organic layers were washed twice with water, washed with, brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography, eluting with MeOH/CH 2 Cl 2 (10%-30%), to give the product as a tan solid (71 mg, 17%).

4-(5-benzyl-4-(4-((dimethylamino)methyl)-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

In a sealed tube was added 1-(4-(5-benzyl-2-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylphenyl)-N,N-dimethylmethanamine (70.7 mg, 0.17 mmol), 4-aminobenzonitrile (78.9 mg, 0.67 mmol), TFE (1.1 mL) and TFA (0.1 mL, 1.3 mmol). The reaction mixture was stirred at 90° C. for 16 h. Upon completion of the reaction, the resulting mixture was cooled, diluted with water, and washed with EtOAc. The combined organic layers were washed with NaHCO 3 solution and with brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography, eluting with MeOH/CH 2 Cl 2 (20%-40%), to give the product as a tan solid (17 mg, 20%).

4-(4-(4-((dimethylamino)methyl)-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

The benzyl group was removed according to the same procedure as described for example 13.

›Example 15

5-benzyl-2-chloro-4-(2,6-dimethyl-4-nitrophenoxy)-5H-pyrrolo[3,2-d]pyrimidine

To a stirred solution of NaH (61.9 mg, 2.6 mmol) in dry NMP (4.7 mL) was added 2,6-dimethyl-4-nitrophenol (258.9 mg, 1.55 mmol) and stirred at room temperature for 30 min under argon. The reaction mixture was added to a solution of 5-benzyl-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine (431 mg, 1.55 mmol) in dry NMP (4 mL) and heated at 90° C. for 16 h. After completion of the reaction, the resulting mixture was diluted with water and washed with EtOAc. The combined organic layers were washed twice with water, washed with brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography, eluting with hexanes:ethyl acetate (3:1-1:1), to give the product as a white solid (598 mg, 94%).

4-(5-benzyl-4-(2,6-dimethyl-4-nitrophenoxy)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

In a sealed tube was added 5-benzyl-2-chloro-4-(2,6-dimethyl-4-nitrophenoxy)-5H-pyrrolo[3,2-d]pyrimidine (598 mg, 1.46 mmol), 4-aminobenzonitrile (691 mg, 5.85 mmol), TFE (9.1 mL) and TFA (1.97 mL, 11.7 mmol). The reaction mixture was stirred at 90° C. for 16 h. Upon completion of the reaction, the resulting mixture was cooled, diluted with water and washed with EtOAc. The combined organic layers were washed with NaHCO 3 , brine, dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography, eluting with hexanes:ethyl acetate (3:1-1:1), to give the product (442 mg, 60%).

›Example 16

4-(4-(4-Acetyl-2,6-dimethylphenoxy)-7-chloro-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

To a solution of 4-(4-(4-acetyl-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile (13 mg, 0.03 mmol) in CH 2 Cl 2 (1 mL) was added NCS (4.4 mg, 0.03 mmol) and the mixture refluxed for 16 h. After the completion of the reaction, the solvent was concentrated and purified by preparative TLC eluting with hexanes:ethyl acetate (2:1) to give the product (4.2 mg, 30%).

›Example 17

4-(7-Chloro-4-(mesitylthio)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

To a solution of 4-(4-(mesitylthio)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile (10 mg, 0.02 mmol) in CH 2 Cl 2 (5 mL) was added NCS (2.8 mg, 0.02 mmol) and the resolution mixture refluxed for 16 h. After the completion of the reaction, the solvent was concentrated and purified by preparative TLC, eluting with hexanes:ethyl acetate (3:1), to give the product (8.8 mg, 88%).

›Example 18

4-(7-bromo-4-(mesitylthio)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

To a solution of 4-(4-(mesitylthio)-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile (22.7 mg, 0.06 mmol) in CH 2 Cl 2 (10 mL) was added NBS (10.5 mg, 0.06 mmol) and the resultant mixture was refluxed for 16 h. After completion of the reaction, the solvent was concentrated and purified by reversed phase HPLC to give the product as a white solid (6.4 mg, 23%).

›Example 19

4-(7-chloro-4-(mesityloxy)-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile

To a solution of 4-(4-(mesityloxy)-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-2-ylamino)benzonitrile (17.3 mg, 0.05 mmol) in CH 2 Cl 2 (5 mL) was added NCS (6.03 mg, 0.05 mmol) and the resultant mixture was refluxed for 16 h. After completion of the reaction, the solvent was concentrated and purified by preparative TLC, eluting with hexanes:ethyl acetate (3:1), to give the product as an off-white solid (3.4 mg, 6%).

›Example 20

4-(7-Chloro-2-(4-cyanophenylamino)-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

To a solution of 4-(2-(4-cyanophenylamino)-5-methyl-5H-pyrrolo[3,2-a]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile (21.5 mg, 0.06 mmol) in CH 2 Cl 2 (3 mL) was added NCS (7.3 mg, 0.06 mmol) and the resultant mixture was refluxed for 16 h. After completion of the reaction, the solvent was concentrated and purified by preparative TLC, eluting with Hexanes:Ethyl acetate (3:1), to give the product as a light yellow solid (13.2 mg, 56%).

›Example 21

4-(7-Bromo-2-(4-cyanophenylamino)-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

To a solution of 4-(2-(4-cyanophenylamino)-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile (58 mg, 0.15 mmol) in CH 2 Cl 2 (8 mL) was added NBS (29 mg, 0.16 mmol) and the resultant mixture was refluxed for 16 h. After completion of the reaction, the solvent was concentrated and purified by preparative TLC, eluting with hexanes:ethyl acetate (2:1), to give the product as a yellow solid (40 mg, 57%).

›Example 22 · 1 of 2

4-(7-Chloro-2-(4-cyanophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

To a solution of 4-(2-(4-cyanophenylamino)-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile (28.1 mg, 0.07 mmol) in CH 2 Cl 2 (4 mL) was added NCS (9.9 mg, 0.07 mmol) and the resultant mixture was refluxed for 16 h. After completion of the reaction, the solvent was concentrated and purified by preparative TLC eluting with hexanes:ethyl acetate (2:1), to give the product as a pink solid (20 mg, 65%).

Biological Activity

Inhibition of HIV-1 Reverse Transcriptase

Numerous compounds were screened for inhibitory activity against human immunodeficiency virus type 1 (HIV-1) using a high throughput cell-based assay using HIV-1 expressing firefly luciferase as a reporter gene and pseudotyped with vesicular stomatitis virus envelope glycoprotein (VSV-G). Experimental procedures were essentially as described by Connor et al. in Journal of Virology (1996), 70: 5306-5311 (Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection), and Popik et al. in Journal of Virology (2002), 76: 4709-4722 (Human immunodeficiency virus type 1 uses lipid raft-co-localized CD4 and chemokine receptors for productive entry into CD4+ T cells). It should be particularly appreciated that the virus contains two introduced mutations in the RT gene (K103N and Y181C, created by PCR mutagenesis) that render the virus highly resistant to current non-nucleoside HIV-1 drugs. Virus stocks were generated by cotransfection of plasmid DNA encoding VSV-G with vector pNL4-3Env(−)Luc(+) into 293T cells. Sixty-four hours after transfection, virus-containing medium was collected by centrifugation and stored frozen at −80° C.

HeLa cells were infected with the VSV-G pseudotyped virus in the presence of screening compounds in a 384-well microtiter plate format. Forty-eight hours after initial infection, lysis buffer and Luciferase Assay Reagent (Promega) was added to the cells and luciferase activity was determined by counting the resultant luminescence using a LJL luminometer. Since the luciferase gene is carried in the virus genome, its expression level directly reflects the virus replication level in the presence of a compound.

To evaluate the activity of the compounds against wild type HIV-1, the HeLa-JC53 cell line that expresses high levels of CD4 and CCR5 (see e.g., Platt et al. in Journal of Virology (1998), 72: 2855-2864: Effect of CCR5 and CD4 cell surface concentrations on infection by macrophagetropic isolates of human immunodeficiency virus type 1) was modified by isolation of a stable cell line that expresses luciferase under the control of the HIV-1 promoter (long terminal repeat, i.e., LTR). HIV-1 infection of this cell line stimulates the transcription of luciferase from the HIV-1 promoter and the luciferase gene expression level is proportional to the level of virus replication (Harrington et al. in Journal of Virology Methods (2000), 88: 111-115: Direct detection of infection of HIV-1 in blood using a centrifugation-indicator cell assay; and Roos et al. in Virology (2000), 273: 307-315: LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SW replication). Procedures for virus infection, compound testing and luciferase activity determination were the same as for the VSV-G pseudotyped HIV-1.

Two approaches were used to evaluate the cytotoxicity of the positive compounds discovered in the HIV-1 virus assays. The first approach employed another modified HeLa-JC53 cell line that constitutively expresses high level of luciferase without virus infection. The level of luciferase expression in these cells served as an indicator for cell replication in the presence of the compounds. Procedures for compound testing and luciferase activity determination were the same as for the virus infection tests. The other toxicity assay utilized HeLe-JC53 cells and a commercially available MTS assay kit (Promega) that measures the mitochondria function of the cells.

Results

The results are listed in Table A as EC50 (nM) and IC50 (nM). Table legend: A is <10, B is between 10 and 100, C is >100, ND is not determined. Note that many compounds of this invention exhibit activities on wild-type (WT) and resistant mutants below 10 nM.

TABLE A EC 50 EC 50 WT EC 50 EC 50 L100I- Cpd Structure (nM) Y181C (nM) Y188L (nM) K103N (nM) 1 A B B B CLogP: 6.31119 2 A B B C CLogP: 7.1942 3 A A A A CLogP: 5.24519 4 A B B B CLogP: 7.00339 5 A A A A CLogP: 5.71888 6 A B B B CLogP: 6.67519 7 A A B B CLogP: 5.85982 8 B C C C CLogP: 8.36608 9 A C C C CLogP: 5.81219 10 A B B B CLogP: 6.65919 11 A B A B CLogP: 6.5252 12 B C C C CLogP: 4.43498 13 A A A A CLogP: 5.18408 14 A C C C CLogP: 6.24839 15 B C C C CLogP: 4.67978 16 C C C C CLogP: 6.01359 17 A B A B CLogP: 4.79382 18 B C C C CLogP: 7.04473 19 A A A B CLogP: 6.16288 20 A B C C CLogP: 6.67638 21 A B B C CLogP: 6.10888 22 A C C C CLogP: 7.12038 23 A A A B CLogP: 6.50038 24 B C C C CLogP: 4.46648 25 A A A B CLogP: 4.65288 26 A B B C CLogP: 5.71308 27 A B B B CLogP: 7.17134 28 A A B B CLogP: 6.94438 29 A C C C CLogP: 6.01638 30 C C C C CLogP: 5.42063 31 A B A B CLogP: 6.34288 32 A B C C CLogP: 6.67638 33 A B B B CLogP: 6.75519 34 A A B B CLogP: 6.41174 35 A B C C CLogP: 6.18265 36 A B C C CLogP: 5.71888 37 A A A A CLogP;: 6.52119 38 B C C C CLogP: 7.16147 39 C C C C CLogP: 7.16147 40 B B C B CLogP: 6.60982 41 A A B B CLogP: 7.16208 42 A A A A CLogP: 5.45519 43 B B C B CLogP: 6.95418 44 B C C C CLogP: 7.19878 45 A A A B CLogP: 5.46143 46 C C C C CLogP: 6.29507 47 B B C C CLogP: 8.67208 48 B B C C CLogP: 9.11123 49 A A A A CLogP: 6.18873 50 A A B C CLogP: 4.02888 51 A A A B CLogP: 7.4042 52 A A A A CLogP: 6.96519 53 A B B C CLogP: 8.13777 54 A B B C CLogP: 9.83084 55 A B B C CLogP: 8.28777 56 B B B B CLogP: 7.88168 57 A A A A CLogP: 6.46008 58 B B C C CLogP: 8.59208 59 B B B B CLogP: 7.17968 60 A A B B CLogP: 7.16808 61 A A A A CLogP: 5.46119 62 A A A A CLogP: 7.39368 63 B B C C CLogP: 8.44208 64 A B C C CLogP: 8.22808 65 A A A C CLogP: 6.02219 66 A A A A CLogP: 6.73519 67 A A B A CLogP: 6.19473 68 A A A A CLogP: 5.39408 69 A A A A CLogP: 6.11368 70 A A A A CLogP: 6.26368 71 A A A A CLogP: 6.86919

›Example 22 · 2 of 2

Contemplated Compounds and Prophetic Examples

In addition to the examples listed above, this invention provides or contemplates many compounds, examples of which are shown in the tables that follow.

Additional contemplated and prophetic examples, which are not exhaustive but merely representative of this invention, are shown below:

›Tables in the description — 3
TABLE 1 — Contemplated Compounds of Formula IA-1 IA-1
ArVWZ
1.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNHCH 3
2.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNbenzylCH 3
3.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNbenzylH
4.o,o′-diCH 3 O-p-(CH═CHCN)phenylCN3-Me-benzylCH 3
5.o,o′-diCH 3 O-p-(CH═CHCN)phenylCN4-Me-benzylH
6.o,o′-diCH 3 O-p-(CH═CHCN)phenylCN3-MeO-benzylH
7.o,o′-diCH 3 O-p-(CH═CHCN)phenylCN4-MeO-benzylCH 3
8.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNHH
9.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNHBr
10.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNcyclopropylCH 2 CH 3
11.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNCH 2 CF 3CH 2 CH 3
12.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNHCH 3
13.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNbenzylCH 3
14.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNbenzylH
15.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCN3-Me-benzylcyclopropyl
16.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCN3-MeO-benzylbenzyl
17.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNHH
18.o,o′-diCH 3 O-p-(CH═CHCN)phenylC≡CCH 3CH 2 CH 3CH 3
19.o,o′-diCH 3 O-p-(CH═CHCN)phenylClCH 2 CH═CH 2H
20.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 CH 3CH 2 CH═CH 2H
21.o,o′-diCH 3 O-p-(CH═CHCN)phenylClCH 2 CH 3CH 2 CH 3
22.o,o′-diCH 3 O-p-(CH═CHCN)phenylClHH
23.4-cyclopropylnaphth-1-ylCNHCH 3
24.4-cyclopropylnaphth-1-ylCNbenzylCH 3
25.4-cyclopropylnaphth-1-ylCNbenzylH
26.4-cyclopropylnaphth-1-ylCNHH
27.4-cyclopropylnaphth-1-ylCH═CHCNHCH 3
28.4-cyclopropylnaphth-1-ylCH═CHCNbenzylCH 3
29.4-cyclopropylnaphth-1-ylCH═CHCNbenzylH
30.4-cyclopropylnaphth-1-ylCH═CHCNHH
31.4-cyclopropylnaphth-1-ylSO 2 NHCH 3CH 2 CNF
32.4-cyclopropylnaphth-1-ylSO 2 NHCH 3cyclopropylCl
33.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 2 CH 2 CNBr
34.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 2 CNbenzyl
35.o,o′-di-CH 3 O-p-CN-phenylC≡CCH 33-MeO-benzylF
36.o,o′-di-CH 3 O-p-CN-phenylF3-Me-benzylCl
37.o,o′-di-CH 3 O-p-CN-phenylCNHCH 3
38.o,o′-di-CH 3 O-p-CN-phenylCNbenzylCH 3
39.o,o′-di-CH 3 O-p-CN-phenylCNbenzylH
40.o,o′-di-CH 3 O-p-CN-phenylCNHH
41.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNHCH 3
42.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNbenzylCH 3
43.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNbenzylH
44.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNHH
45.o,o′-di-CH 3 -p-CN-phenylCNHCH 3
46.o,o′-di-CH 3 -p-CN-phenylCNbenzylCH 3
47.o,o′-di-CH 3 -p-CN-phenylCN3,5-di MeO-benzylCH 3
48.o,o′-di-CH 3 -p-CN-phenylCNbenzylH
49.o,o′-di-CH 3 -p-CN-phenylCNHH
50.o,o′-di-CH 3 -p-CN-phenylCH═CHCNHCH 3
51.o,o′-di-CH 3 -p-CN-phenylCH═CHCNbenzylCH 3
52.o,o′-di-CH 3 -p-CN-phenylCH═CHCNbenzylH
53.o,o′-di-CH 3 -p-CN-phenylCH═CHCNHH
54.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNHF
55.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNbenzylF
56.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNbenzylF
57.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNHF
58.4-cyclopropylnaphth-1-ylCNHF
59.4-cyclopropylnaphth-1-ylCNbenzylF
60.4-cyclopropylnaphth-1-ylCH═CHCNHF
61.4-cyclopropylnaphth-1-ylCH═CHCNbenzylF
62.o,o′-di-CH 3 O-p-CN-phenylCNHF
63.o,o′-di-CH 3 O-p-CN-phenylCNbenzylF
64.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNHF
65.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNbenzylF
66.o,o′-di-CH 3 -p-CN-phenylCNHF
67.o,o′-di-CH 3 -p-CN-phenylCNbenzylF
68.o,o′-di-CH 3 -p-CN-phenylCH═CHCNHF
69.o,o′-di-CH 3 -p-CN-phenylCH═CHCNbenzylF
70.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2HCH 3
71.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2benzylCH 3
72.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2benzylH
73.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2HH
74.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2HCH 3
75.o,o′-diCH 3 O-p-(CH═CHCN)phenylFbenzylCH 3
76.o,o′-diCH 3 O-p-(CH═CHCN)phenylFbenzylH
77.o,o′-diCH 3 O-p-(CH═CHCN)phenylFHH
78.4-cyclopropylnaphth-1-ylSO 2 NH 2HCH 3
79.4-cyclopropylnaphth-1-ylSO 2 NH 2benzylCH 3
80.4-cyclopropylnaphth-1-ylSO 2 NH 2benzylH
81.4-cyclopropylnaphth-1-ylSO 2 NH 2HH
82.4-cyclopropylnaphth-1-ylFHCH 3
83.4-cyclopropylnaphth-1-ylFbenzylCH 3
84.4-cyclopropylnaphth-1-ylFbenzylH
85.4-cyclopropylnaphth-1-ylFHH
86.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2HCH 3
87.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2benzylCH 3
88.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2benzylH
89.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2HH
90.o,o′-di-CH 3 O-p-CN-phenylFHCH 3
91.o,o′-di-CH 3 O-p-CN-phenylFbenzylCH 3
92.o,o′-di-CH 3 O-p-CN-phenylFbenzylH
93.o,o′-di-CH 3 O-p-CN-phenylFHH
94.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2HCH 3
95.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2benzylCH 3
96.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 23-Me-benzylCH 3
97.o,o′-di-CH 3 -p-CN-phenylSO 2 NHCH 3benzylH
98.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2benzylH
99.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2HH
100.o,o′-di-CH 3 -p-CN-phenylFHCH 3
101.o,o′-di-CH 3 -p-CN-phenylFbenzylCH 3
102.o,o′-di-CH 3 -p-CN-phenylFbenzylH
103.o,o′-di-CH 3 -p-CN-phenylFHH
104.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2HF
105.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2benzylF
106.o,o′-diCH 3 O-p-(CH═CHCN)phenylFbenzylF
107.o,o′-diCH 3 O-p-(CH═CHCN)phenylFHF
108.4-cyclopropylnaphth-1-ylSO 2 NH 2HF
109.4-cyclopropylnaphth-1-ylSO 2 NH 2benzylF
110.4-cyclopropylnaphth-1-ylFHF
111.4-cyclopropylnaphth-1-ylFbenzylF
112.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2HF
113.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2benzylF
114.o,o′-di-CH 3 O-p-CN-phenylFHF
115.o,o′-di-CH 3 O-p-CN-phenylFbenzylF
116.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2HF
117.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2benzylF
118.o,o′-di-CH 3 -p-CN-phenylFHF
119.o,o′-di-CH 3 -p-CN-phenylFbenzylF
120.2,4,6-trimethyl phenylCNHCH 3
121.2,4,6-trimethyl phenylCNbenzylCH 3
122.2,4,6-trimethyl phenylCNbenzylH
123.2,4,6-trimethyl phenylCNHH
124.2,4,6-trimethyl phenylCH═CHCNHCH 3
125.2,4,6-trimethyl phenylCH═CHCNbenzylCH 3
126.2,4,6-trimethyl phenylCH═CHCNbenzylH
127.2,4,6-trimethyl phenylCH═CHCNHH
128.2,4,6-trimethyl phenylCNHF
129.2,4,6-trimethyl phenylCNbenzylF
130.2,4,6-trimethyl phenylCH═CHCNHF
131.2,4,6-trimethyl phenylCH═CHCNbenzylF
132.2,4,6-trimethyl phenylSO 2 NH 2HCH 3
133.2,4,6-trimethyl phenylSO 2 NH 2benzylCH 3
134.2,4,6-trimethyl phenylSO 2 NH 2benzylH
135.2,4,6-trimethyl phenylSO 2 NH 2HH
136.2,4,6-trimethyl phenylFHCH 3
137.2,4,6-trimethyl phenylFbenzylCH 3
138.2,4,6-trimethyl phenylFbenzylH
139.4-cyclopropyl phenylFHH
140.4-cyclopropyl phenylSO 2 NH 2HF
141.4-cyclopropyl phenylSO 2 NH 2benzylF
142.4-cyclopropyl phenylFHF
143.4-cyclopropyl phenylFbenzylF
144.o,o′-dimethyl-p-cyclopropyl phenylCNHCH 3
145.o,o′-dimethyl-p-cyclopropyl phenylCNbenzylCH 3
146.o,o′-dimethyl-p-cyclopropyl phenylCNbenzylH
147.o,o′-dimethyl-p-cyclopropyl phenylCNHH
148.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNHCH 3
149.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNbenzylCH 3
150.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNbenzylH
151.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNHH
152.o,o′-dimethyl-p-cyclopropyl phenylCNHF
153.o,o′-dimethyl-p-cyclopropyl phenylCNbenzylF
154.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNHF
155.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNbenzylF
156.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2HCH 3
157.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2benzylCH 3
158.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2benzylH
159.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2HH
160.o,o′-dimethyl-p-cyclopropyl phenylFHCH 3
161.o,o′-dimethyl-p-cyclopropyl phenylFbenzylCH 3
162.o,o′-dimethyl-p-cyclopropyl phenylFbenzylH
163.o,o′-dimethyl-p-cyclopropyl phenylFHH
164.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2HF
165.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2benzylF
166.o,o′-dimethyl-p-cyclopropyl phenylFHF
167.o,o′-dimethyl-p-cyclopropyl phenylFbenzylF
168.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNCH 3CH 3
169.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNcyclopropylCH 3
170.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNcyclopropylH
171.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNCH 3H
172.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNCH 3CH 3
173.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNcyclopropylCH 3
174.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNcyclopropylH
175.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNCH 3H
176.4-cyclopropylnaphth-1-ylCNCH 3CH 3
177.4-cyclopropylnaphth-1-ylCNcyclopropylCH 3
178.4-cyclopropylnaphth-1-ylCNcyclopropylH
179.4-cyclopropylnaphth-1-ylCNCH 3H
180.4-cyclopropylnaphth-1-ylCH═CHCNCH 3CH 3
181.4-cyclopropylnaphth-1-ylCH═CHCNcyclopropylCH 3
182.4-cyclopropylnaphth-1-ylCH═CHCNcyclopropylH
183.4-cyclopropylnaphth-1-ylCH═CHCNCH 3H
184.o,o′-di-CH 3 O-p-CN-phenylCNCH 3CH 3
185.o,o′-di-CH 3 O-p-CN-phenylCNcyclopropylCH 3
186.o,o′-di-CH 3 O-p-CN-phenylCNcyclopropylH
187.o,o′-di-CH 3 O-p-CN-phenylCNCH 3H
188.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 3CH 3
189.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNcyclopropylCH 3
190.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNcyclopropylH
191.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 3H
192.o,o′-di-CH 3 -p-CN-phenylCNCH 3CH 3
193.o,o′-di-CH 3 -p-CN-phenylCNcyclopropylCH 3
194.o,o′-di-CH 3 -p-CN-phenylCNcyclopropylH
195.o,o′-di-CH 3 -p-CN-phenylCNCH 3H
196.o,o′-di-CH 3 -p-CN-phenylCH═CHCNCH 3CH 3
197.o,o′-di-CH 3 -p-CN-phenylCH═CHCNcyclopropylCH 3
198.o,o′-di-CH 3 -p-CN-phenylCH═CHCNcyclopropylH
199.o,o′-di-CH 3 -p-CN-phenylCH═CHCNCH 3H
200.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNCH 3F
201.o,o′-diCH 3 O-p-(CH═CHCN)phenylCNcyclopropylF
202.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNcyclopropylF
203.o,o′-diCH 3 O-p-(CH═CHCN)phenylCH═CHCNCH 3F
204.4-cyclopropylnaphth-1-ylCNCH 3F
205.4-cyclopropylnaphth-1-ylCNcyclopropylF
206.4-cyclopropylnaphth-1-ylCH═CHCNCH 3F
207.4-cyclopropylnaphth-1-ylCH═CHCNcyclopropylF
208.o,o′-di-CH 3 O-p-CN-phenylCNCH 3F
209.o,o′-di-CH 3 O-p-CN-phenylCNcyclopropylF
210.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 3F
211.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNcyclopropylF
212.o,o′-di-CH 3 -p-CN-phenylCNCH 3F
213.o,o′-di-CH 3 -p-CN-phenylCNcyclopropylF
214.o,o′-di-CH 3 -p-CN-phenylCH═CHCNCH 3F
215.o,o′-di-CH 3 -p-CN-phenylCH═CHCNcyclopropylF
216.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2CH 3CH 3
217.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2cyclopropylCH 3
218.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2cyclopropylH
219.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2CH 3H
220.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2CH 3CH 3
221.o,o′-diCH 3 O-p-(CH═CHCN)phenylFcyclopropylCH 3
222.o,o′-diCH 3 O-p-(CH═CHCN)phenylFcyclopropylH
223.o,o′-diCH 3 O-p-(CH═CHCN)phenylFCH 3H
224.4-cyclopropylnaphth-1-ylSO 2 NH 2CH 3CH 3
225.4-cyclopropylnaphth-1-ylSO 2 NH 2cyclopropylCH 3
226.4-cyclopropylnaphth-1-ylSO 2 NH 2cyclopropylH
227.4-cyclopropylnaphth-1-ylSO 2 NH 2CH 3H
228.4-cyclopropylnaphth-1-ylFCH 3CH 3
229.4-cyclopropylnaphth-1-ylFcyclopropylCH 3
230.4-cyclopropylnaphth-1-ylFcyclopropylH
231.4-cyclopropylnaphth-1-ylFCH 3H
232.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 3CH 3
233.o,o′-di-CH 3 O-p-CN-phenylSO 2 NHCH 3CH 3CH 3
234.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2cyclopropylCH 3
235.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2cyclopropylH
236.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 3H
237.o,o′-di-CH 3 O-p-CN-phenylFCH 3CH 3
238.o,o′-di-CH 3 O-p-CN-phenylFcyclopropylCH 3
239.o,o′-di-CH 3 O-p-CN-phenylFcyclopropylH
240.o,o′-di-CH 3 O-p-CN-phenylFCH 3H
241.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2CH 3CH 3
242.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2cyclopropylCH 3
243.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2cyclopropylH
244.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2CH 3H
245.o,o′-di-CH 3 -p-CN-phenylFCH 3CH 3
246.o,o′-di-CH 3 -p-CN-phenylFcyclopropylCH 3
247.o,o′-di-CH 3 -p-CN-phenylFcyclopropylH
248.o,o′-di-CH 3 -p-CN-phenylFCH 3H
249.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2CH 3F
250.o,o′-diCH 3 O-p-(CH═CHCN)phenylSO 2 NH 2cyclopropylF
251.o,o′-diCH 3 O-p-(CH═CHCN)phenylFcyclopropylF
252.o,o′-diCH 3 O-p-(CH═CHCN)phenylFCH 3F
253.4-cyclopropylnaphth-1-ylSO 2 NH 2CH 3F
254.4-cyclopropylnaphth-1-ylSO 2 NH 2cyclopropylF
255.4-cyclopropylnaphth-1-ylFCH 3F
256.4-cyclopropylnaphth-1-ylFcyclopropylF
257.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 3F
258.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2cyclopropylF
259.o,o′-di-CH 3 O-p-CN-phenylFCH 3F
260.o,o′-di-CH 3 O-p-CN-phenylFcyclopropylF
261.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2CH 3F
262.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2cyclopropylF
263.o,o′-di-CH 3 -p-CN-phenylFCH 3F
264.o,o′-di-CH 3 -p-CN-phenylFcyclopropylF
265.4-cyclopropyl phenylCNCH 3CH 3
266.2,4,6-trimethyl phenylCNcyclopropylCH 3
267.2,4,6-trimethyl phenylCNcyclopropylH
268.2,4,6-trimethyl phenylCNCH 3H
269.2,4,6-trimethyl phenylCH═CHCNCH 3CH 3
270.2,4,6-trimethyl phenylCH═CHCNcyclopropylCH 3
271.2,4,6-trimethyl phenylCH═CHCNcyclopropylH
272.2,4,6-trimethyl phenylCH═CHCNCH 3H
273.2,4,6-trimethyl phenylCNCH 3F
274.2,4,6-trimethyl phenylCNcyclopropylF
275.2,4,6-trimethyl phenylCH═CHCNCH 3F
276.2,4,6-trimethyl phenylCH═CHCNcyclopropylF
277.2,4,6-trimethyl phenylSO 2 NH 2CH 3CH 3
278.2,4,6-trimethyl phenylSO 2 NH 2cyclopropylCH 3
279.2,4,6-trimethyl phenylSO 2 NH 2cyclopropylH
280.2,4,6-trimethyl phenylSO 2 NH 2CH 3H
281.2,4,6-trimethyl phenylFCH 3CH 3
282.2,4,6-trimethyl phenylFcyclopropylCH 3
283.2,4,6-trimethyl phenylFcyclopropylH
284.4-cyclopropyl phenylFCH 3H
285.4-cyclopropyl phenylSO 2 NH 2CH 3F
286.4-cyclopropyl phenylSO 2 NH 2cyclopropylF
287.4-cyclopropyl phenylFCH 3F
288.4-cyclopropyl phenylFcyclopropylF
289.2,4,6-trimethyl phenylCNCH 3CH 3
290.o,o′-dimethyl-p-cyclopropyl phenylCNcyclopropylCH 3
291.o,o′-dimethyl-p-cyclopropyl phenylCNcyclopropylH
292.o,o′-dimethyl-p-cyclopropyl phenylCNCH 3H
293.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNCH 3CH 3
294.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNcyclopropylCH 3
295.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNcyclopropylH
296.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNCH 3H
297.o,o′-dimethyl-p-cyclopropyl phenylCNCH 3F
298.o,o′-dimethyl-p-cyclopropyl phenylCNcyclopropylF
299.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNCH 3F
300.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNcyclopropylF
301.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2CH 3CH 3
302.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2cyclopropylCH 3
303.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2cyclopropylH
304.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2CH 3H
305.o,o′-dimethyl-p-cyclopropyl phenylFCH 3CH 3
306.o,o′-dimethyl-p-cyclopropyl phenylFcyclopropylCH 3
307.o,o′-dimethyl-p-cyclopropyl phenylFcyclopropylH
308.2,4,6-trimethyl phenylFCH 3H
309.2,4,6-trimethyl phenylSO 2 NH 2CH 3F
310.2,4,6-trimethyl phenylSO 2 NH 2cyclopropylF
311.2,4,6-trimethyl phenylFCH 3F
312.2,4,6-trimethyl phenylFcyclopropylF
313.o,o′-di-CH 3 -p-acetyl-phenylCNCH 3H
314.o,o′-di-CH 3 -p-acetyl-phenylCNHH
315.o,o′-di-CH 3 -p-acetyl-phenylCNCH 3Cl
316.o,o′-di-CH 3 -p-acetyl-phenylCNHCl
TABLE 2 — Contemplated Compounds of Formula IA-2
ArVWZ
1.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCNFCH 3
2.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCNbenzylCH 3
3.o,o′--diCH 3 O-p-(CH═CHCN)-phenylCNbenzylH
4.o,o′--diCH 3 O-p-(CH═CHCN)-phenylCNFH
5.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCH═CHCNClCH 3
6.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCH═CHCNbenzylCH 3
7.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCH═CHCNbenzylH
8.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCH═CHCNClH
9.4-cyclopropylnaphth-1-ylC≡CCH 3allylethyl
10.4-cyclopropylnaphth-1-ylCNallylethyl
11.4-cyclopropylnaphth-1-ylCNbenzylH
12.4-cyclopropylnaphth-1-ylCNbenzylH
13.4-cyclopropylnaphth-1-ylC≡CCH 3allylethyl
14.4-cyclopropylnaphth-1-ylCH═CHCNallylethyl
15.4-cyclopropylnaphth-1-ylCH═CHCN3-MeO-benzylH
16.4-cyclopropylnaphth-1-ylCH═CHCNbenzylH
17.o,o′-di-CH 3 O-p-CN-phenylSO 2 NHCH 3CH═CHCNCH 3
18.o,o′-di-CH 3 O-p-CN-phenylCNCH═CHCNCH 3
19.o,o′-di-CH 3 O-p-CN-phenylCN3-Me-benzylH
20.o,o′-di-CH 3 O-p-CN-phenylCNbenzylH
21.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH═CHCNCH 3
22.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 2 CH 2 CNCH 3
23.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 2 CH 2 CNH
24.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNbenzylH
25.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCNCH 3H
26.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCNCH 3benzyl
27.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCNHbenzyl
28.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCNHH
29.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCH═CHCNCH 3H
30.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCH═CHCNCH 3benzyl
31.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCH═CHCNHbenzyl
32.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCH═CHCNHH
33.4-cyclopropylnaphth-1-ylCNCH 3H
34.4-cyclopropylnaphth-1-ylCNCH 3benzyl
35.4-cyclopropylnaphth-1-ylCNHbenzyl
36.4-cyclopropylnaphth-1-ylCNHH
37.4-cyclopropylnaphth-1-ylCH═CHCNCH 3H
38.4-cyclopropylnaphth-1-ylCH═CHCNCH 3benzyl
39.4-cyclopropylnaphth-1-ylCH═CHCNHbenzyl
40.4-cyclopropylnaphth-1-ylCH═CHCNHH
41.o,o′-di-CH 3 O-p-CN-phenylCNCH 3H
42.o,o′-di-CH 3 O-p-CN-phenylCNCH 3benzyl
43.o,o′-di-CH 3 O-p-CN-phenylCNHbenzyl
44.o,o′-di-CH 3 O-p-CN-phenylCNHH
45.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 3H
46.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 3benzyl
47.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNHbenzyl
48.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNHH
49.o,o′-di-CH 3 -p-CN-phenylCNCH 3H
50.o,o′-di-CH 3 -p-CN-phenylCNCH 3benzyl
51.o,o′-di-CH 3 -p-CN-phenylCNHbenzyl
52.o,o′-di-CH 3 -p-CN-phenylCNHH
53.o,o′-di-CH 3 -p-CN-phenylCH═CHCNCH 3H
54.o,o′-di-CH 3 -p-CN-phenylCH═CHCNCH 3benzyl
55.o,o′-di-CH 3 -p-CN-phenylCH═CHCNHbenzyl
56.o,o′-di-CH 3 -p-CN-phenylCH═CHCNHH
57.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCNFH
58.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCNFbenzyl
59.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCH═CHCNFbenzyl
60.o,o′-di-CH 3 O-p-(CH═CHCN)-phenylCH═CHCNFH
61.4-cyclopropylnaphth-1-ylCNFH
62.4-cyclopropylnaphth-1-ylCNFbenzyl
63.4-cyclopropylnaphth-1-ylCH═CHCNFH
64.4-cyclopropylnaphth-l-ylCH═CHCNFbenzyl
65.o,o′-di-CH 3 O-p-CN-phenylCNFH
66.o,o′-di-CH 3 O-p-CN-phenylCNFbenzyl
67.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNFH
68.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNFbenzyl
69.o,o′-di-CH 3 -p-CN-phenylCNFH
70.o,o′-di-CH 3 -p-CN-phenylCNFbenzyl
71.o,o′-di-CH 3 -p-CN-phenylCH═CHCNFH
72.o,o′-di-CH 3 -p-CN-phenylCH═CHCNFbenzyl
73.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2CH 3H
74.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2CH 3benzyl
75.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2Hbenzyl
76.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2HH
77.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2CH 3H
78.o,o′-diCH 3 O-p-(CH═CHCN)-phenylFCH 3benzyl
79.o,o′-diCH 3 O-p-(CH═CHCN)-phenylFHbenzyl
80.o,o′-diCH 3 O-p-(CH═CHCN)-phenylFHH
81.4-cyclopropylnaphth-1-ylSO 2 NH 2CH 3H
82.4-cyclopropylnaphth-1-ylSO 2 NH 2CH 3benzyl
83.4-cyclopropylnaphth-1-ylSO 2 NH 2Hbenzyl
84.4-cyclopropylnaphth-1-ylSO 2 NH 2HH
85.4-cyclopropylnaphth-1-ylFCH 3H
86.4-cyclopropylnaphth-1-ylFCH 3benzyl
87.4-cyclopropylnaphth-1-ylFHbenzyl
88.4-cyclopropylnaphth-1-ylFHH
89.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 3H
90.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 3benzyl
91.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2Hbenzyl
92.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2HH
93.o,o′-di-CH 3 O-p-CN-phenylFCH 3H
94.o,o′-di-CH 3 O-p-CN-phenylFCH 3benzyl
95.o,o′-di-CH 3 O-p-CN-phenylFHbenzyl
96.o,o′-di-CH 3 O-p-CN-phenylFHH
97.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2CH 3H
98.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2CH 3benzyl
99.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2Hbenzyl
100.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2HH
101.o,o′-di-CH 3 -p-CN-phenylFCH 3H
102.o,o′-di-CH 3 -p-CN-phenylFCH 3benzyl
103.o,o′-di-CH 3 -p-CN-phenylFHbenzyl
104.o,o′-di-CH 3 -p-CN-phenylFHH
105.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2FH
106.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2Fbenzyl
107.o,o′-diCH 3 O-p-(CH═CHCN)-phenylFFbenzyl
108.o,o′-diCH 3 O-p-(CH═CHCN)-phenylFFH
109.4-cyclopropylnaphth-1-ylSO 2 NH 2FH
110.4-cyclopropylnaphth-1-ylSO 2 NH 2Fbenzyl
111.4-cyclopropylnaphth-1-ylFFH
112.4-cyclopropylnaphth-1-ylFFbenzyl
113.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2FH
114.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2Fbenzyl
115.o,o′-di-CH 3 O-p-CN-phenylFFH
116.o,o′-di-CH 3 O-p-CN-phenylFFbenzyl
117.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2FH
118.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2Fbenzyl
119.o,o′-di-CH 3 -p-CN-phenylFFH
120.o,o′-di-CH 3 -p-CN-phenylFFbenzyl
121.4-cyclopropyl phenylCNCH 3H
122.4-cyclopropyl phenylCNCH 3benzyl
123.4-cyclopropyl phenylCNHbenzyl
124.4-cyclopropyl phenylCNHH
125.2,4,6-trimethyl phenylCH═CHCNCH 3H
126.2,4,6-trimethyl phenylCH═CHCNCH 3benzyl
127.2,4,6-trimethyl phenylCH═CHCNHbenzyl
128.2,4,6-trimethyl phenylCH═CHCNHH
129.2,4,6-trimethyl phenylCNFH
130.2,4,6-trimethyl phenylCNFbenzyl
131.2,4,6-trimethyl phenylCH═CHCNFH
132.2,4,6-trimethyl phenylCH═CHCNFbenzyl
133.2,4,6-trimethyl phenylSO 2 NH 2CH 3H
134.2,4,6-trimethyl phenylSO 2 NH 2CH 3benzyl
135.2,4,6-trimethyl phenylSO 2 NH 2Hbenzyl
136.2,4,6-trimethyl phenylSO 2 NH 2HH
137.2,4,6-trimethyl phenylFCH 3H
138.2,4,6-trimethyl phenylFCH 3benzyl
139.2,4,6-trimethyl phenylFHbenzyl
140.4-cyclopropyl phenylFHH
141.4-cyclopropyl phenylSO 2 NH 2FH
142.4-cyclopropyl phenylSO 2 NH 2Fbenzyl
143.4-cyclopropyl phenylFFH
144.4-cyclopropyl phenylFFbenzyl
145.o,o′-dimethyl-p-cyclopropyl phenylCNCH 3H
146.o,o′-dimethyl-p-cyclopropyl phenylCNCH 3benzyl
147.o,o′-dimethyl-p-cyclopropyl phenylCNHbenzyl
148.o,o′-dimethyl-p-cyclopropyl phenylCNHH
149.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNCH 3H
150.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNCH 3benzyl
151.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNHbenzyl
152.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNHH
153.o,o′-dimethyl-p-cyclopropyl phenylCNFH
154.o,o′-dimethyl-p-cyclopropyl phenylCNFbenzyl
155.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNFH
156.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNFbenzyl
157.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2CH 3H
158.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2CH 3benzyl
159.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2Hbenzyl
160.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2HH
161.o,o′-dimethyl-p-cyclopropyl phenylFCH 3H
162.o,o′-dimethyl-p-cyclopropyl phenylFCH 3benzyl
163.o,o′-dimethyl-p-cyclopropyl phenylFHbenzyl
164.o,o′-dimethyl-p-cyclopropyl phenylFHH
165.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2FH
166.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2Fbenzyl
167.2-methyl-4-cyclopropyl phenylFFH
168.2-methyl-4-cyclopropyl phenylFFbenzyl
169.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCNCH 3CH 3
170.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCNCH 3cyclopropyl
171.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCNHcyclopropyl
172.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCNHCH 3
173.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCH═CHCNCH 3CH 3
174.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCH═CHCNCH 3cyclopropyl
175.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCH═CHCNHcyclopropyl
176.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCH═CHCNHCH 3
177.4-cyclopropylnaphth-1-ylCNCH 3CH 3
178.4-cyclopropylnaphth-1-ylCNCH 3cyclopropyl
179.4-cyclopropylnaphth-1-ylCNHcyclopropyl
180.4-cyclopropylnaphth-1-ylCNHCH 3
181.4-cyclopropylnaphth-1-ylCH═CHCNCH 3CH 3
182.4-cyclopropylnaphth-1-ylCH═CHCNCH 3cyclopropyl
183.4-cyclopropylnaphth-1-ylCH═CHCNHcyclopropyl
184.4-cyclopropylnaphth-1-ylCH═CHCNHCH 3
185.o,o′-di-CH 3 O-p-CN-phenylCNCH 3CH 3
186.o,o′-di-CH 3 O-p-CN-phenylCNCH 3cyclopropyl
187.o,o′-di-CH 3 O-p-CN-phenylCNHcyclopropyl
188.o,o′-di-CH 3 O-p-CN-phenylCNHCH 3
189.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 3CH 3
190.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 3cyclopropyl
191.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNHcyclopropyl
192.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNHCH 3
193.o,o′-di-CH 3 -p-CN-phenylCNCH 3CH 3
194.o,o′-di-CH 3 -p-CN-phenylCNCH 3cyclopropyl
195.o,o′-di-CH 3 -p-CN-phenylCNHcyclopropyl
196.o,o′-di-CH 3 -p-CN-phenylCNHCH 3
197.o,o′-di-CH 3 -p-CN-phenylCH═CHCNCH 3CH 3
198.o,o′-di-CH 3 -p-CN-phenylCH═CHCNCH 3cyclopropyl
199.o,o′-di-CH 3 -p-CN-phenylCH═CHCNHcyclopropyl
200.o,o′-di-CH 3 -p-CN-phenylCH═CHCNHCH 3
201.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCNFCH 3
202.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCNFcyclopropyl
203.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCH═CHCNFcyclopropyl
204.o,o′-diCH 3 O-p-(CH═CHCN)-phenylCH═CHCNFCH 3
205.4-cyclopropylnaphth-1-ylCNFCH 3
206.4-cyclopropylnaphth-1-ylCNFcyclopropyl
207.4-cyclopropylnaphth-1-ylCH═CHCNFCH 3
208.4-cyclopropylnaphth-1-ylCH═CHCNFcyclopropyl
209.o,o′-di-CH 3 O-p-CN-phenylCNFCH 3
210.o,o′-di-CH 3 O-p-CN-phenylCNFcyclopropyl
211.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNFCH 3
212.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNFcyclopropyl
213.o,o′-di-CH 3 -p-CN-phenylCNFCH 3
214.o,o′-di-CH 3 -p-CN-phenylCNFcyclopropyl
215.o,o′-di-CH 3 -p-CN-phenylCH═CHCNFCH 3
216.o,o′-di-CH 3 -p-CN-phenylCH═CHCNFcyclopropyl
217.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2CH 3CH 3
218.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2CH 3cyclopropyl
219.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2Hcyclopropyl
220.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2HCH 3
221.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2CH 3CH 3
222.o,o′-diCH 3 O-p-(CH═CHCN)-phenylFCH 3cyclopropyl
223.o,o′-diCH 3 O-p-(CH═CHCN)-phenylFHcyclopropyl
224.o,o′-diCH 3 O-p-(CH═CHCN)-phenylFHCH 3
225.4-cyclopropylnaphth-1-ylSO 2 NH 2CH 3CH 3
226.4-cyclopropylnaphth-1-ylSO 2 NH 2CH 3cyclopropyl
227.4-cyclopropylnaphth-1-ylSO 2 NH 2Hcyclopropyl
228.4-cyclopropylnaphth-1-ylSO 2 NH 2HCH 3
229.4-cyclopropylnaphth-1-ylFCH 3CH 3
230.4-cyclopropylnaphth-1-ylFCH 3cyclopropyl
231.4-cyclopropylnaphth-1-ylFHcyclopropyl
232.4-cyclopropylnaphth-1-ylFHCH 3
233.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 3CH 3
234.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 3cyclopropyl
235.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2Hcyclopropyl
236.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2HCH 3
237.o,o′-di-CH 3 O-p-CN-phenylFCH 3CH 3
238.o,o′-di-CH 3 O-p-CN-phenylFCH 3cyclopropyl
239.o,o′-di-CH 3 O-p-CN-phenylFHcyclopropyl
240.o,o′-di-CH 3 O-p-CN-phenylFHCH 3
241.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2CH 3CH 3
242.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2CH 3cyclopropyl
243.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2Hcyclopropyl
244.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2HCH 3
245.o,o′-di-CH 3 -p-CN-phenylFCH 3CH 3
246.o,o′-di-CH 3 -p-CN-phenylFCH 3cyclopropyl
247.o,o′-di-CH 3 -p-CN-phenylFHcyclopropyl
248.o,o′-di-CH 3 -p-CN-phenylFHCH 3
249.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2FCH 3
250.o,o′-diCH 3 O-p-(CH═CHCN)-phenylSO 2 NH 2Fcyclopropyl
251.o,o′-diCH 3 O-p-(CH═CHCN)-phenylFFcyclopropyl
252.o,o′-diCH 3 O-p-(CH═CHCN)-phenylFFCH 3
253.4-cyclopropylnaphth-1-ylSO 2 NH 2FCH 3
254.4-cyclopropylnaphth-1-ylSO 2 NH 2Fcyclopropyl
255.4-cyclopropylnaphth-1-ylFFCH 3
256.4-cyclopropylnaphth-1-ylFFcyclopropyl
257.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2FCH 3
258.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2Fcyclopropyl
259.o,o′-di-CH 3 O-p-CN-phenylFFCH 3
260.o,o′-di-CH 3 O-p-CN-phenylFFcyclopropyl
261.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2FCH 3
262.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2Fcyclopropyl
263.o,o′-di-CH 3 -p-CN-phenylFFCH 3
264.o,o′-di-CH 3 -p-CN-phenylFFcyclopropyl
265.4-cyclopropyl phenylCNCH 3CH 3
266.2,4,6-trimethyl phenylCNCH 3cyclopropyl
267.2,4,6-trimethyl phenylCNHcyclopropyl
268.2,4,6-trimethyl phenylCNHCH 3
269.2,4,6-trimethyl phenylCH═CHCNCH 3CH 3
270.2,4,6-trimethyl phenylCH═CHCNCH 3cyclopropyl
271.2,4,6-trimethyl phenylCH═CHCNHcyclopropyl
272.2,4,6-trimethyl phenylCH═CHCNHCH 3
273.2,4,6-trimethyl phenylCNFCH 3
274.2,4,6-trimethyl phenylCNFcyclopropyl
275.2,4,6-trimethyl phenylCH═CHCNFCH 3
276.2,4,6-trimethyl phenylCH═CHCNFcyclopropyl
277.2,4,6-trimethyl phenylSO 2 NH 2CH 3CH 3
278.2,4,6-trimethyl phenylSO 2 NH 2CH 3cyclopropyl
279.2,4,6-trimethyl phenylSO 2 NH 2Hcyclopropyl
280.2,4,6-trimethyl phenylSO 2 NH 2HCH 3
281.2,4,6-trimethyl phenylFCH 3CH 3
282.2,4,6-trimethyl phenylFCH 3cyclopropyl
283.2,4,6-trimethyl phenylFHcyclopropyl
284.2,4,6-trimethyl phenylFHCH 3
285.2,4,6-trimethyl phenylSO 2 NH 2FCH 3
286.4-cyclopropyl phenylSO 2 NH 2Fcyclopropyl
287.4-cyclopropyl phenylFFCH 3
288.4-cyclopropyl phenylFFcyclopropyl
289.o,o′-dimethyl-p-cyclopropyl phenylCNCH 3CH 3
290.o,o′-dimethyl-p-cyclopropyl phenylCNCH 3cyclopropyl
291.o,o′-dimethyl-p-cyclopropyl phenylCNHcyclopropyl
292.o,o′-dimethyl-p-cyclopropyl phenylCNHCH 3
293.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNCH 3CH 3
294.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNCH 3cyclopropyl
295.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNHcyclopropyl
296.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNHCH 3
297.o,o′-dimethyl-p-cyclopropyl phenylCNFCH 3
298.o,o′-dimethyl-p-cyclopropyl phenylCNFcyclopropyl
299.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNFCH 3
300.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNFcyclopropyl
301.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2CH 3CH 3
302.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2CH 3cyclopropyl
303.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2Hcyclopropyl
304.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2HCH 3
305.o,o′-dimethyl-p-cyclopropyl phenylFCH 3CH 3
306.o,o′-dimethyl-p-cyclopropyl phenylFCH 3cyclopropyl
307.o,o′-dimethyl-p-cyclopropyl phenylFHcyclopropyl
308.o,o′-dimethyl-p-cyclopropyl phenylFHCH 3
309.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2FCH 3
310.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2Fcyclopropyl
311.o,o′-dimethyl-p-cyclopropyl phenylFFCH 3
312.o,o′-dimethyl-p-cyclopropyl phenylFFcyclopropyl
313.o,o′-di-CH 3 -p-acetyl-phenylCNHH
314.o,o′-di-CH 3 -p-acetyl-phenylCNCH 3H
315.o,o′-di-CH 3 -p-acetyl-phenylCNHCl
316.o,o′-di-CH 3 -p-acetyl-phenylCNCH 3Cl
TABLE 3 — Contemplated Compounds of Formula IA-3
ArVWZ
1.o,o′-diCH 3 O-p-(CH═CHCN)-CNbenzylF
phenyl
2.o,o′-diCH 3 O-p-(CH═CHCN)-CNbenzylCl
phenyl
3.o,o′-diCH 3 O-p-(CH═CHCN)-CNallylF
phenyl
4.o,o′-diCH 3 O-p-(CH═CHCN)-CNallylCl
phenyl
5.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNbenzylCH 3
phenyl
6.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCN3-MeO-CH 3
phenylbenzyl
7.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCN3-Me-CH 3
phenylbenzyl
8.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNallylCH 3
phenyl
9.4-cyclopropylnaphth-1-ylCNCH 2 CH 3H
10.4-cyclopropylnaphth-1-ylCNisopropylH
11.4-cyclopropylnaphth-1-ylCNCH 2 CF 3Br
12.4-cyclopropylnaphth-1-ylCNCH 2 CF 3Cl
13.4-cyclopropylnaphth-1-ylCH═CHCNCH 2 CH 3H
14.4-cyclopropylnaphth-1-ylCH═CHCNCH 2 CH 3Br
15.4-cyclopropylnaphth-1-ylCH═CHCNCH 2 CF 3CH 3
16.4-cyclopropylnaphth-1-ylCH═CHCNCH 2 CF 3H
17.o,o′-di-CH 3 O-p-CN-phenylCNbenzylF
18.o,o′-di-CH 3 O-p-CN-phenylCNbenzylCl
19.o,o′-di-CH 3 O-p-CN-phenylCNallylF
20.o,o′-di-CH 3 O-p-CN-phenylCNallylCl
21.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNbenzylCH 3
22.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNbenzylBr
23.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNallylCH 3
24.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNallylH
25.o,o′-diCH 3 O-p-(CH═CHCN)-CNHF
phenyl
26.o,o′-diCH 3 O-p-(CH═CHCN)-CNbenzylCl
phenyl
27.o,o′-diCH 3 O-p-(CH═CHCN)-CNbenzylH
phenyl
28.o,o′-diCH 3 O-p-(CH═CHCN)-CNHH
phenyl
29.o,o′-diCH 3 O-p-(CH═CHCN)-CNHCH 3
phenyl
30.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNbenzylCH 3
phenyl
31.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNbenzylH
phenyl
32.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNHH
phenyl
33.4-cyclopropylnaphth-1-ylCNHCH 3
34.4-cyclopropylnaphth-1-ylCNbenzylCH 3
35.4-cyclopropylnaphth-1-ylCNbenzylH
36.4-cyclopropylnaphth-1-ylCNHH
37.4-cyclopropylnaphth-1-ylCH═CHCNHCH 3
38.4-cyclopropylnaphth-1-ylCH═CHCNbenzylCH 3
39.4-cyclopropylnaphth-1-ylCH═CHCNbenzylH
40.4-cyclopropylnaphth-1-ylCH═CHCNHH
41.o,o′-di-CH 3 O-p-CN-phenylCNHCH 3
42.o,o′-di-CH 3 O-p-CN-phenylCNbenzylCH 3
43.o,o′-di-CH 3 O-p-CN-phenylCNbenzylH
44.o,o′-di-CH 3 O-p-CN-phenylCNHH
45.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNHCH 3
46.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNbenzylCH 3
47.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNbenzylH
48.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNHH
49.o,o′-di-CH 3 -p-CN-phenylCNHCH 3
50.o,o′-di-CH 3 -p-CN-phenylCNbenzylCH 3
51.o,o′-di-CH 3 -p-CN-phenylCNbenzylH
52.o,o′-di-CH 3 -p-CN-phenylCNHH
53.o,o′-di-CH 3 -p-CN-phenylCH═CHCNHCH 3
54.o,o′-di-CH 3 -p-CN-phenylCH═CHCNbenzylCH 3
55.o,o′-di-CH 3 -p-CN-phenylCH═CHCNbenzylH
56.o,o′-di-CH 3 -p-CN-phenylCH═CHCNHH
57.o,o′-diCH 3 O-p-(CH═CHCN)-CNHF
phenyl
58.o,o′-diCH 3 O-p-(CH═CHCN)-CNbenzylF
phenyl
59.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNbenzylF
phenyl
60.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNHF
phenyl
61.4-cyclopropylnaphth-1-ylCNHF
62.4-cyclopropylnaphth-1-ylCNbenzylF
63.4-cyclopropylnaphth-1-ylCH═CHCNHF
64.4-cyclopropylnaphth-1-ylCH═CHCNbenzylF
65.o,o′-di-CH 3 O-p-CN-phenylCNHF
66.o,o′-di-CH 3 O-p-CN-phenylCNbenzylF
67.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNHF
68.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNbenzylF
69.o,o′-di-CH 3 -p-CN-phenylCNHF
70.o,o′-di-CH 3 -p-CN-phenylCNbenzylF
71.o,o′-di-CH 3 -p-CN-phenylCH═CHCNHF
72.o,o′-di-CH 3 -p-CN-phenylCH═CHCNbenzylF
73.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2HCH 3
phenyl
74.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2benzylCH 3
phenyl
75.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2benzylH
phenyl
76.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2HH
phenyl
77.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2HCH 3
phenyl
78.o,o′-diCH 3 O-p-(CH═CHCN)-FbenzylCH 3
phenyl
79.o,o′-diCH 3 O-p-(CH═CHCN)-FbenzylH
phenyl
80.o,o′-diCH 3 O-p-(CH═CHCN)-FHH
phenyl
81.4-cyclopropylnaphth-1-ylSO 2 NH 2HCH 3
82.4-cyclopropylnaphth-1-ylSO 2 NH 2benzylCH 3
83.4-cyclopropylnaphth-1-ylSO 2 NH 2benzylH
84.4-cyclopropylnaphth-1-ylSO 2 NH 2HH
85.4-cyclopropylnaphth-1-ylFHCH 3
86.4-cyclopropylnaphth-1-ylFbenzylCH 3
87.4-cyclopropylnaphth-1-ylFbenzylH
88.4-cyclopropylnaphth-1-ylFHH
89.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2HCH 3
90.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2benzylCH 3
91.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2benzylH
92.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2HH
93.o,o′-di-CH 3 O-p-CN-phenylFHCH 3
94.o,o′-di-CH 3 O-p-CN-phenylFbenzylCH 3
95.o,o′-di-CH 3 O-p-CN-phenylFbenzylH
96.o,o′-di-CH 3 O-p-CN-phenylFHH
97.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2HCH 3
98.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2benzylCH 3
99.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2benzylH
100.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2HH
101.o,o′-di-CH 3 -p-CN-phenylFHCH 3
102.o,o′-di-CH 3 -p-CN-phenylFbenzylCH 3
103.o,o′-di-CH 3 -p-CN-phenylFbenzylH
104.o,o′-di-CH 3 -p-CN-phenylFHH
105.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2HF
phenyl
106.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2benzylF
phenyl
107.o,o′-diCH 3 O-p-(CH═CHCN)-FbenzylF
phenyl
108.o,o′-diCH 3 O-p-(CH═CHCN)-FHF
phenyl
109.4-cyclopropylnaphth-1-ylSO 2 NH 2HF
110.4-cyclopropylnaphth-1-ylSO 2 NH 2benzylF
111.4-cyclopropylnaphth-1-ylFHF
112.4-cyclopropylnaphth-1-ylFbenzylF
113.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2HF
114.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2benzylF
115.o,o′-di-CH 3 O-p-CN-phenylFHF
116.o,o′-di-CH 3 O-p-CN-phenylFbenzylF
117.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2HF
118.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2benzylF
119.o,o′-di-CH 3 -p-CN-phenylFHF
120.o,o′-di-CH 3 -p-CN-phenylFbenzylF
121.2,4,6-trimethyl phenylCNHCH 3
122.2,4,6-trimethyl phenylCNbenzylCH 3
123.2,4,6-trimethyl phenylCNbenzylH
124.2,4,6-trimethyl phenylCNHH
125.2,4,6-trimethyl phenylCH═CHCNHCH 3
126.2,4,6-trimethyl phenylCH═CHCNbenzylCH 3
127.4-cyclopropyl phenylCH═CHCNbenzylH
128.4-cyclopropyl phenylCH═CHCNHH
129.4-cyclopropyl phenylCNHF
130.4-cyclopropyl phenylCNbenzylF
131.4-cyclopropyl phenylCH═CHCNHF
132.2,4,6-trimethyl phenylCH═CHCNbenzylF
133.2,4,6-trimethyl phenylSO 2 NH 2HCH 3
134.2,4,6-trimethyl phenylSO 2 NH 2benzylCH 3
135.2,4,6-trimethyl phenylSO 2 NH 2benzylH
136.2,4,6-trimethyl phenylSO 2 NH 2HH
137.2,4,6-trimethyl phenylFHCH 3
138.2,4,6-trimethyl phenylFbenzylCH 3
139.2,4,6-trimethyl phenylFbenzylH
140.2,4,6-trimethyl phenylFHH
141.2,4,6-trimethyl phenylSO 2 NH 2HF
142.2,4,6-trimethyl phenylSO 2 NH 2benzylF
143.2,4,6-trimethyl phenylFHF
144.2,4,6-trimethyl phenylFbenzylF
145.2,4,6-trimethyl phenylCNHCH 3
146.2,4,6-trimethyl phenylCNbenzylCH 3
147.2,4,6-trimethyl phenylCNbenzylH
148.2,4,6-trimethyl phenylCNHH
149.2,4,6-trimethyl phenylCH═CHCNHCH 3
150.2,4,6-trimethyl phenylCH═CHCNbenzylCH 3
151.2,4,6-trimethyl phenylCH═CHCNbenzylH
152.2,4,6-trimethyl phenylCH═CHCNHH
153.2,4,6-trimethyl phenylCNHF
154.2,4,6-trimethyl phenylCNbenzylF
155.2,4,6-trimethyl phenylCH═CHCNHF
156.2,4,6-trimethyl phenylCH═CHCNbenzylF
157.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2HCH 3
158.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2benzylCH 3
159.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2benzylH
160.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2HH
161.o,o′-dimethyl-p-cyclopropyl phenylFHCH 3
162.o,o′-dimethyl-p-cyclopropyl phenylFbenzylCH 3
163.o,o′-dimethyl-p-cyclopropyl phenylFbenzylH
164.o,o′-dimethyl-p-cyclopropyl phenylFHH
165.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2HF
166.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2benzylF
167.o,o′-dimethyl-p-cyclopropyl phenylFHF
168.o,o′-dimethyl-p-cyclopropyl phenylFbenzylF
169.o,o′-diCH 3 O-p-(CH═CHCN)-CNCH 3CH 3
phenyl
170.o,o′-diCH 3 O-p-(CH═CHCN)-CNcyclo-CH 3
phenylpropyl
171.o,o′-diCH 3 O-p-(CH═CHCN)-CNcyclo-H
phenylpropyl
172.o,o′-diCH 3 O-p-(CH═CHCN)-CNCH 3H
phenyl
173.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNCH 3CH 3
phenyl
174.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNcyclo-CH 3
phenylpropyl
175.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNcyclo-H
phenylpropyl
176.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNCH 3H
phenyl
177.4-cyclopropylnaphth-1-ylCNCH 3CH 3
178.4-cyclopropylnaphth-1-ylCNcyclo-CH 3
propyl
179.4-cyclopropylnaphth-1-ylCNcyclo-H
propyl
180.4-cyclopropylnaphth-1-ylCNCH 3H
181.4-cyclopropylnaphth-1-ylCH═CHCNCH 3CH 3
182.4-cyclopropylnaphth-1-ylCH═CHCNcyclo-CH 3
propyl
183.4-cyclopropylnaphth-1-ylCH═CHCNcyclo-H
propyl
184.4-cyclopropylnaphth-1-ylCH═CHCNCH 3H
185.o,o′-di-CH 3 O-p-CN-phenylCNCH 3CH 3
186.o,o′-di-CH 3 O-p-CN-phenylCNcyclo-CH 3
propyl
187.o,o′-di-CH 3 O-p-CN-phenylCNcyclo-H
propyl
188.o,o′-di-CH 3 O-p-CN-phenylCNCH 3H
189.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 3CH 3
190.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNcyclo-CH 3
propyl
191.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNcyclo-H
propyl
192.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 3H
193.o,o′-di-CH 3 -p-CN-phenylCNCH 3CH 3
194.o,o′-di-CH 3 -p-CN-phenylCNcyclo-CH 3
propyl
195.o,o′-di-CH 3 -p-CN-phenylCNcyclo-H
propyl
196.o,o′-di-CH 3 -p-CN-phenylCNCH 3H
197.o,o′-di-CH 3 -p-CN-phenylCH═CHCNCH 3CH 3
198.o,o′-di-CH 3 -p-CN-phenylCH═CHCNcyclo-CH 3
propyl
199.o,o′-di-CH 3 -p-CN-phenylCH═CHCNcyclo-H
propyl
200.o,o′-di-CH 3 -p-CN-phenylCH═CHCNCH 3H
201.o,o′-diCH 3 O-p-(CH═CHCN)-CNCH 3F
phenyl
202.o,o′-diCH 3 O-p-(CH═CHCN)-CNcyclo-F
phenylpropyl
203.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNcyclo-F
phenylpropyl
204.o,o′-diCH 3 O-p-(CH═CHCN)-CH═CHCNCH 3F
phenyl
205.4-cyclopropylnaphth-1-ylCNCH 3F
206.4-cyclopropylnaphth-1-ylCNcyclo-F
propyl
207.4-cyclopropylnaphth-1-ylCH═CHCNCH 3F
208.4-cyclopropylnaphth-1-ylCH═CHCNcyclo-F
propyl
209.o,o′-di-CH 3 O-p-CN-phenylCNCH 3F
210.o,o′-di-CH 3 O-p-CN-phenylCNcyclo-F
propyl
211.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNCH 3F
212.o,o′-di-CH 3 O-p-CN-phenylCH═CHCNcyclo-F
propyl
213.o,o′-di-CH 3 -p-CN-phenylCNCH 3F
214.o,o′-di-CH 3 -p-CN-phenylCNcyclo-F
propyl
215.o,o′-di-CH 3 -p-CN-phenylCH═CHCNCH 3F
216.o,o′-di-CH 3 -p-CN-phenylCH═CHCNcyclo-F
propyl
217.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2CH 3CH 3
phenyl
218.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2cyclo-CH 3
phenylpropyl
219.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2cyclo-H
phenylpropyl
220.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2CH 3H
phenyl
221.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2CH 3CH 3
phenyl
222.o,o′-diCH 3 O-p-(CH═CHCN)-Fcyclo-CH 3
phenylpropyl
223.o,o′-diCH 3 O-p-(CH═CHCN)-Fcyclo-H
phenylpropyl
224.o,o′-diCH 3 O-p-(CH═CHCN)-FCH 3H
phenyl
225.4-cyclopropylnaphth-1-ylSO 2 NH 2CH 3CH 3
226.4-cyclopropylnaphth-1-ylSO 2 NH 2cyclo-CH 3
propyl
227.4-cyclopropylnaphth-1-ylSO 2 NH 2cyclo-H
propyl
228.4-cyclopropylnaphth-1-ylSO 2 NH 2CH 3H
229.4-cyclopropylnaphth-1-ylFCH 3CH 3
230.4-cyclopropylnaphth-1-ylFcyclo-CH 3
propyl
231.4-cyclopropylnaphth-1-ylFcyclo-H
propyl
232.4-cyclopropylnaphth-1-ylFCH 3H
233.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 3CH 3
234.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2cyclo-CH 3
propyl
235.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2cyclo-H
propyl
236.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 3H
237.o,o′-di-CH 3 O-p-CN-phenylFCH 3CH 3
238.o,o′-di-CH 3 O-p-CN-phenylFcyclo-CH 3
propyl
239.o,o′-di-CH 3 O-p-CN-phenylFcyclo-H
propyl
240.o,o′-di-CH 3 O-p-CN-phenylFCH 3H
241.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2CH 3CH 3
242.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2cyclo-CH 3
propyl
243.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2cyclo-H
propyl
244.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2CH 3H
245.o,o′-di-CH 3 -p-CN-phenylFCH 3CH 3
246.o,o′-di-CH 3 -p-CN-phenylFcyclo-CH 3
propyl
247.o,o′-di-CH 3 -p-CN-phenylFcyclo-H
propyl
248.o,o′-di-CH 3 -p-CN-phenylFCH 3H
249.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2CH 3F
phenyl
250.o,o′-diCH 3 O-p-(CH═CHCN)-SO 2 NH 2cyclo-F
phenylpropyl
251.o,o′-diCH 3 O-p-(CH═CHCN)-Fcyclo-F
phenylpropyl
252.o,o′-diCH 3 O-p-(CH═CHCN)-FCH 3F
phenyl
253.4-cyclopropylnaphth-1-ylSO 2 NH 2CH 3F
254.4-cyclopropylnaphth-1-ylSO 2 NH 2cyclo-F
propyl
255.4-cyclopropylnaphth-1-ylFCH 3F
256.4-cyclopropylnaphth-1-ylFcyclo-F
propyl
257.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2CH 3F
258.o,o′-di-CH 3 O-p-CN-phenylSO 2 NH 2cyclo-F
propyl
259.o,o′-di-CH 3 O-p-CN-phenylFCH 3F
260.o,o′-di-CH 3 O-p-CN-phenylFcyclo-F
propyl
261.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2CH 3F
262.o,o′-di-CH 3 -p-CN-phenylSO 2 NH 2cyclo-F
propyl
263.o,o′-di-CH 3 -p-CN-phenylFCH 3F
264.o,o′-di-CH 3 -p-CN-phenylFcyclo-F
propyl
265.4-cyclopropyl phenylCNCH 3CH 3
266.4-cyclopropyl phenylCNcyclo-CH 3
propyl
267.2,4,6-trimethyl phenylCNcyclo-H
propyl
268.2,4,6-trimethyl phenylCNCH 3H
269.2,4,6-trimethyl phenylCH═CHCNCH 3CH 3
270.2,4,6-trimethyl phenylCH═CHCNcyclo-CH 3
propyl
271.2,4,6-trimethyl phenylCH═CHCNcyclo-H
propyl
272.2,4,6-trimethyl phenylCH═CHCNCH 3H
273.2,4,6-trimethyl phenylCNCH 3F
274.2,4,6-trimethyl phenylCNcyclo-F
propyl
275.2,4,6-trimethyl phenylCH═CHCNCH 3F
276.2,4,6-trimethyl phenylCH═CHCNcyclo-F
propyl
277.2,4,6-trimethyl phenylSO 2 NH 2CH 3CH 3
278.2,4,6-trimethyl phenylSO 2 NH 2cyclo-CH 3
propyl
279.2,4,6-trimethyl phenylSO 2 NH 2cyclo-H
propyl
280.2,4,6-trimethyl phenylSO 2 NH 2CH 3H
281.2,4,6-trimethyl phenylFCH 3CH 3
282.2,4,6-trimethyl phenylFcyclo-CH 3
propyl
283.2,4,6-trimethyl phenylFcyclo-H
propyl
284.2,4,6-trimethyl phenylFCH 3H
285.4-cyclopropyl phenylSO 2 NH 2CH 3F
286.4-cyclopropyl phenylSO 2 NH 2cyclo-F
propyl
287.4-cyclopropyl phenylFCH 3F
288.4-cyclopropyl phenylFcyclo-F
propyl
289.2,4,6-trimethyl phenylCNCH 3CH 3
290.2,4,6-trimethyl phenylCNcyclo-CH 3
propyl
291.o,o′-dimethyl-p-cyclopropyl phenylCNcyclo-H
propyl
292.o,o′-dimethyl-p-cyclopropyl phenylCNCH 3H
293.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNCH 3CH 3
294.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNcyclo-CH 3
propyl
295.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNcyclo-H
propyl
296.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNCH 3H
297.o,o′-dimethyl-p-cyclopropyl phenylCNCH 3F
298o,o′-dimethyl-p-cyclopropyl phenylCNcyclo-F
propyl
299.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNCH 3F
300.o,o′-dimethyl-p-cyclopropyl phenylCH═CHCNcyclo-F
propyl
301.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2CH 3CH 3
302.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2cyclo-CH 3
propyl
303.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2cyclo-H
propyl
304.o,o′-dimethyl-p-cyclopropyl phenylSO 2 NH 2CH 3H
305.o,o′-dimethyl-p-cyclopropyl phenylFCH 3CH 3
306.o,o′-dimethyl-p-cyclopropyl phenylFcyclo-CH 3
propyl
307.o,o′-dimethyl-p-cyclopropyl phenylFcyclo-H
propyl
308.o,o′-dimethyl-p-cyclopropyl phenylFCH 3H
309.2,4,6-trimethyl phenylSO 2 NH 2CH 3F
310.2,4,6-trimethyl phenylSO 2 NH 2cyclo-F
propyl
311.2,4,6-trimethyl phenylFCH 3F
312.2,4,6-trimethyl phenylFcyclo-F
propyl
313.o,o′-di-CH 3 -p-acetyl-phenylCNHH
314.o,o′-di-CH 3 -p-acetyl-phenylCNCH 3H
315.o,o′-di-CH 3 -p-acetyl-phenylCNHCl
316.o,o′-di-CH 3 -p-acetyl-phenylCNCH 3Cl

Claims as granted

14 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

2 codes
IPC · International Patent Classification
Section C — Chemistry; metallurgy
  • C07D487/00
USPC · US Patent Classification
544/280

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomAprMayJunJulAugSepOctNovDec2013FebMarUSPTOApplicantNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
0.7 y
249 days filing → grant
Office actions
0
none on record
Responses
1
no RCE
Examiner
Jeffrey Murray
art unit 1624 · TC 1600
Citations: 45 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom20122014201620182020202220242026202820302032Owner 2
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock